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Abstract 
Fifty community-dwelling adults aged 51-83 years of age (M=70.1, SD=7.61) reported 
their medication compliance and their use of memory strategies. The first goal of the 
present study was to replicate Gould McDonald-Miszczak, and King’s (1997) research on 
older adults’ use of memory strategies to aid medication compliance. As in the Gould et 
al. (1997) study, older adults reported using internal strategies more often than external 
strategies for medication compliance, and the use of strategies was predicted by 
metamemorial variables (p<.05) rather than by objective health related factors. The 
second goal of this study was to extend the research by Gould et al. (1997), who found 
that metamemorial variables, rather than objective medical factors, were significant 
predictors of self-reported medication compliance. The present study used a new self- 
report measure of compliance, and examined cognitive performance in addition to health 
related and metamemorial assessments. The self-report measure of compliance was tied 
more to objective health factors than to subjective beliefs, as medical factors contributed 
significantly to the prediction of self-reported compliance (p=.05). Finally, a 
metacognitive path model specific to self-reported compliance was tested, and the 
importance of compliance, a belief laden variable, predicted self-reported compliance 
through prospective strategy use. The results of this study suggest that medication 
compliance is a complex mixture of both objective health related factors and subjective 
metacognitive assessments. 
Chapter One: Introduction 
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Older Adults’ Use of Memory Strategies and Self-reported Medication Compliance 
There are declines in the natural aging process and often disease processes can 
accompany later life. However, in order to facilitate a high quality later life, many of 
these declines can be effectively treated with the proper use of medications. Older adults 
often require multiple medications for numerous chronic conditions and as the number of 
medications increases, so does the complexity of the medication task. This increasing 
complexity often leads to decreasing compliance. 
Lower compliance with medication instructions can lead to lower drug 
effectiveness along with many other negative effects. Nevertheless despite these 
negative effects, noncompliance with medication regimens is quite common. The use of 
memory strategies, however, can often improve compliance in older adults. Although the 
usefulness of many memory strategies for older adults has been demonstrated, very little 
is known about the strategies that older adults choose to employ outside the laboratory, or 
about why these strategies are chosen to aid compliance with medication regimens. 
There are many ways to measure medication compliance. However the most 
commonly used method of measuring compliance is the self-report and, unfortunately, 
this is not always the most accurate method. While many studies investigate the accuracy 
of compliance measures, including the self-report and other more accurate measures using 
new technology, very few attempt to improve the accuracy of the commonly used self- 
report measure of compliance. Yet it is the self-report on which many physicians and 
older adults routinely base important medication decisions, and consequently, it is the 
self-report that needs to be investigated in order to improve its accuracy. The three goals 
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of the present study are to replicate Gould et al.’s, 1997 research on older adults’ use of 
memory strategies, to extend their research through examination of a new self-report 
measure of compliance, and to test a metacognitive path model specific to self-reported 
compliance. 
An Aging Population 
Older adults make up a large part of our population, and the proportion of older 
adults is constantly increasing (Facts on Aging in Canada, 1996; Statistics Canada, 1997) 
in most parts of the world (Shuman, 1987; Woodruff-Pak, 1988). In has been projected 
that, between 1975 and 2025, the global population of older adults will have increased by 
350% (Shuman, 1987). Adults over 55 years of age made up 21% of Canada’s 
population in 1998, and are expected to make up over 28% and 34% of the population by 
the years 2016 and 2026 respectively (Statistics Canada, 1997). 
Not only has the proportion of older adults in our society been increasing, but life 
expectancy has also been increasing (Fries, 1990). People can now look forward to an 
optimal life expectancy of approximately 80 years (Statistics Canada, 1992b); an increase 
of 28-38 years since the turn of the last century (Fries, 1980; 1990). For those people 
born between 1990 and 1992, life expectancy is 78 years and 81 years for men and 
women respectively (Statistics Canada, 1992b). More than ever, older adults comprise a 
large segment of our population. 
There is some controversy over the projection of future life expectancy. However, 
whether life expectancy continues to increase into the 2F' century (U.S. Bureau of the 
Census, 1989) or whether the increases in future life expectancy will begin to slow (Fries, 
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1980; 1990), people spend more time as older adults today, and the population of older 
adults overall is expected to increase. The increasing number of older adults in our 
society makes it clear that the issues concerning older adults will be of tantamount 
importance in the coming decades. 
Aging and Health 
One issue that is very important to older adults is the issue of maintaining health 
with increasing age. However, both physical and cognitive health can decline with age, 
and in the face of these declines, it can become increasingly difficult for older adults to 
enjoy the benefits of later life. Older adults experience less acute disease than younger 
adults however, over the past century, the national illness burden has shifted from acute 
to chronic illness (Fries, 1990). Chronic heart disease and arthritis have been reported to 
limit the activity of almost one quarter of older adults (Lamy, 1980). Approximately 80% 
of deaths due to circulatory diseases, cancer, and respiratory diseases are in adults over 65 
years of age, and older adults account for 65% of the days spent in hospital for these 
same chronic diseases (Statistics Canada, 1994). 
Often, later life is a time of new found freedom from work and family 
responsibilities, and frequently older adults use this freedom for travel and the pursuit of 
other interests. However, due to declines in physical health, many older adults experience 
difficulty with everyday tasks. In a sample of 28,000 older adults, Leon and Lair (1990) 
found that over 3,600 had difficulty with at least one activity of daily living (ADL), 
primarily with bed and chair transfers, bathing, and walking. Almost 50% of older adults 
report that their activities are limited due to chronic illness (Everitt & Avorn, 1986). Due 
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to declines in cognitive health, many older adults experience frustration and difficulty 
with daily tasks that involve memory. Indeed, despite the accumulation of years of 
wisdom and experience, older adults often report difficulty with their memory as one of 
their primary concerns with aging (Moscovitch, 1982). 
Aging and Medication 
Over time and with increasing age, the average number of chronic conditions 
suffered often increases, and interferes with the active and fulfilling lifestyle many older 
adults enjoy. Such chronic conditions often require long term treatment which frequently 
includes the use of medication. Medications are “one of the most effective and efficient 
medical technologies when used correctly. They are used to treat various afflictions, to 
relieve symptoms and pain, to reduce the number and duration of hospital stays and to 
prevent painful and stressful procedures.” (Government du Quebec, 1995, p. 9). 
Medications are the most commonly used health treatment in North America (Chaiton, 
Walter, Spitzer, Roberts, & Delmore, 1976), and they are even more common among 
older adults (Government du Quebec, 1995; Miller, 1991). 
Older adults in Canada represented 12.4% of the population in 1999, or almost 3.8 
million people (Statistics Canada, 2000). When older adults represented only 11-12% of 
the total population, these older adults consumed from approximately 30% (Delafuente, 
1991; Miller, 1991) to 50% (WHO, 1981 cited in Park et al., 1992) of prescription drugs, 
and accounted for approximately 25% of the total national expenditure for medications 
(Vestal, 1990). Up to 75% of older adults report using prescription drugs on a regular 
basis (Helling, Lemke, Semla, Wallace, Lipson, & Comoni-Huntley, 1987; Ostrom, 
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Hammarlund, Christensen, Plein, & Kethely, 1985). This is consistent with reports that 
80% (Delafuente, 1991; Simonson, 1984b; Swonger & Burbank, 1995) to 86% (German, 
Klein, McPhee, & Smith, 1982) of older adults suffer from at least one chronic condition 
which requires medication. Further, the average amount of overall and prescription 
medication use has been shown to increase with age (Helling et al., 1987). 
When looking at older adults and medication use, it is important to remember that 
older adults suffer from more health conditions than younger adults and as a result, they 
will tend to legitimately use more medication than the general population. Older adults 
report suffering from up to three (Darnell et al., 1986) times more medical conditions 
than the rest of the population, and this is consistent with reports that older adults use two 
to three times more prescription medications (Health and Welfare Canada, 1981; 1990; 
Wells, Kamberg et al., 1985) . 
A variety of researchers have examined physicians’ prescription patterns, and the 
estimates of medical visits that result in a prescription range from 28% up to 75% 
(Davidson, Molloy, Sommers, & Bedard, 1994; Gibson & Waldo, 1981), with the highest 
prescription averages for older adults. These high prescription rates, coupled with the 
many visits older adults make to see their physicians (Minister for Senior Citizens 
Affairs, 1985; Statistics Canada, 1990; 1991), result in large amounts of medication 
consumption by older adults. The average community dwelling older adult has been 
reported to fill as many as 11 prescriptions per year (Shimp, Ascione et al., 1985; 
Unpublished study cited in Philion, 1988). 
Over 90% of older adults are using at least one prescription medication (Hale, 
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May, Marks, and Stewart, 1987; Health and Welfare Canada, 1981) with the average 
older adult using anywhere from two to four prescription medications at one time (Hale et 
ah, 1987; Health and Welfare Canada, 1981; Helling et ah, 1987; Ostrom et ah, 1985; 
Simonson, 1984b). 
Aging and Medication Compliance 
Prescription medications can contribute much to the lives of older adults if they 
are taken properly. Compliance with medication implies compliance with the verbal or 
written “instructions provided regarding the use of medication” (Miller, 1991, p. 46). A 
variety of compliance rates have been demonstrated for different medications due to a 
number of factors, however compliance rates overall tend to be quite low (Weibert & 
Dee, 1980). 
Noncompliance is assumed to be more likely if the patient is very old (Blackwell, 
1973; Park, et al., 1992), yet Christensen and Smith (1995) have reported that older 
patients demonstrated significantly higher compliance than younger patients in their 
sample. Further, it has been noted that “There is a persistent misconception that the 
elderly have a higher rate of noncompliance than younger patients” (Miller, 1991, p. 46) 
and that “Reexamination of earlier literature indicates the rate of compliance in the 
elderly is similar to that in patients of all age groups” (Miller, 1991, p. 46-7; see also 
Boczkowski & Zeichner, 1985). However, the reasons for noncompliance may be 
different for older adults than they are for younger adults, with cognitive factors possibly 
playing a larger role in noncompliance for older adults (Morrell, Park, & Poon, 1989). 
Regardless of the presence or absence of age differences, it remains an important fact that 
A Metacognitive Model 8 
older adults require more medications than the general population to maintain an active 
and healthy lifestyle, and that many are not compliant with their medication regimens. 
This noncompliance needs to be understood, and looking at cognitive factors may help to 
clarify the nature of noncompliance in older adults (Morrell et al., 1989). Opdycke, 
Ascione, Shimp and Rosen (1992) examined a pharmacist intervention program for older 
adults and found that two of the top three problems identified by pharmacists for this 
sample were non-compliance and inappropriate drug use. 
Errors in compliance can be divided into two categories: errors of omission (i.e., 
missed doses), and errors of commission (i.e., taking too much medication, taking the 
wrong medication, or taking the medication at the wrong time). There is a large gap 
between the two types of medication errors such that errors of omission are much more 
common than errors of commission (Bernstein, Folkman, & Lazarus, 1989; Col et al., 
1990; Park et al., 1992; Swonger & Burbank, 1995). More specifically. Park and her 
colleagues reviewed the literature in 1992 and reported that errors of commission were as 
low as 2% while errors of omission ranged from 15% up to 47%. Among those 
participants who were noncompliant in a 1991 study, 70% made errors of omission while 
only 30% made errors of commission (Graveley & Oseasohn). 
Studies have shown that from one-third to over one-half of older adults 
demonstrate some form of noncompliance with their medications (Botelho & Dudrak, 
1992; Carney, Freedland, Eisen, Rich, & Jaffe, 1995; Isaac, Tamblyn, & McGill - Calgary 
Drug Research Team, 1993; Morrow, Leirer, & Sheikh, 1988). Boczkowski and 
Zeichner (1985; see also Simonson, 1984a) reported that it has been consistently 
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documented that regimen complexity (i.e., number of different pills per day and number 
of doses per medication) contributes to noncompliance. Indeed, many studies have found 
that self-reported noncompliance increased with regimen complexity or number of 
medications taken (Bernstein et ah, 1989; Blackwell, 1973; Botelho & Dudrak, 1992; Col 
et ah, 1990; Conn, Taylor, & Kelley, 1991; Darnell et ah, 1986; Graveley & Oseasohn, 
1991) though some have not found this relationship (Isaac et ah, 1993; Park et ah, 1992). 
The relationship between regimen complexity and noncompliance has been well 
explored, and it is clear that older adults are at risk for noncompliance with important 
medication regimens due to the high number of medications taken by the average older 
adult. 
Negative Effects of Noncompliance 
Noncompliance in older adults has many negative consequences including 
ineffective therapy, adverse drug reactions, higher rates of hospital admission, increased 
out-of-pocket expenses, and higher social health care costs through increased length of 
hospital stay and the prescription of additional medications. The accumulation of left- 
over medication is another dangerous result of noncompliance (Simonson, 1984a). Many 
of these consequences pose serious health risks to the older adult and place undo strain on 
the health care system. 
Adverse Drug Reactions fADRs) 
It is important that older adults comply with their medication regimens, not only 
for the primary benefit of their therapy, but also to avoid Adverse Drug Reactions. ADRs 
may be exacerbated by primary (normal changes in physiology), secondary (other changes 
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in physiology that may interact with primary factors), and tertiary (psychosocial stress) 
aging factors. Any of these factors related to aging may interact with pharmacologic 
factors and ADRs can result. (For a review of the general effects of aging on 
pharmacokinetics see Miller, 1991; also see Greenblatt, Sellers, & Shader, 1982). The 
risk of an ADR increases with the number of medications being taken (Col et al., 1990). 
Risk factors include taking more than four medications and documented compliance 
problems before hospital admission (Schneider, Mion, & Frengley, 1992). As described 
earlier, many older adults routinely take more than four medications at one time and are, 
therefore, at increased risk for hospitalization due to ADRs. Further, many older adults 
have demonstrated substantial compliance problems, and are consequently at even greater 
risk for ADRs. Indeed, studies show an increase in ADRs with increasing age (Everitt, & 
Avorn, 1986; Government du Quebec, 1995; Greenblatt et al., 1982). Those over 70 
years of age are reported to suffer from ADRs three times more than adults under 50 
(Smith et al., 1994), and 51% of those who die from ADRs are over 60 years of age 
(Butler, 1989). 
Out-of-pocket Costs for Older Adults 
Not only does the health of an older adult suffer with noncompliance, but there is 
also a considerable financial loss that accompanies noncompliance. The cost of 
medicinal and pharmaceutical products is high and rising. When observed over several 
years by the Consumer Price Index in 1992, medicinal and pharmaceutical products were 
listed as having above average price increases (Statistics Canada, 1992c). Even during a 
time of cuts to health care spending in Canada, drug expenditures have increased rather 
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than decreased in the past decade (Naylor, 1999). An estimated 20% of Canadian older 
adults’ out-of-pocket expenses in 1990 were for medications (The Health and Activity 
Limitation Survey, 1990). Out-of-pocket expenses for prescription medication for older 
adults in the early 1980's doubled the expenses for the total population (including the 
older adults) for all expenditure categories over $50 (Kasper, 1982). In Canada in 1996, 
the average person was responsible for 64.8% of medication expenditures (Naylor, 1999). 
Social Healthcare Costs 
The financial burden for noncompliance with medications falls not only on the 
older adult, but also on each member of our society. Much of the taxpayer’s social health 
care dollar goes toward the research and provision of medication for older adults. The 
Pharmaeare system in British Columbia keeps track of the prescription behaviours of 
older adults in that province. In 1989 the 316,000 adults over 65 years of age filled 4.25 
million preseriptions, at a cost of $91.4 million (Stevenson, Kellogg, Ernst, & Whinney, 
1989). In 1995, $9.3 billion was spent on medications in Canada (Statistics Canada, 
1997), and three billion dollars a year in medication goes to older adults in the United 
States (Vestal, 1990). 
For older adults in Quebec in 1992, the medication expense was $75 million more 
than the expenditure for medical services. Between 1977 and 1992, the budget for 
medication grew almost 17% annually, and older adults were the recipients of the largest 
portion of that growth. This growth in the budget for older adults was not entirely 
justified by a simple increase in population, as the population increased by only 3.1% 
while the average cost of medications increased by 11% (Government du Quebec, 1995). 
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This represents an increase in the financial burden, both for tax payers and for the 
individual older adult who needs the medication, although the distribution of that burden 
varies from province to province (Naylor, 1999). 
Noncompliance with progressively more expensive medications will lead to 
increased costs to the health care system as it continues to research and help provide 
medication for those who need it. Regardless of how effective any medication proves to 
be, if it is not taken properly the money has been wasted and the therapy will be 
ineffective. Further, noncompliance with medication may lead to costly hospitalization, 
and to further prescriptions in an effort to achieve therapeutic results. 
Hospitalization for Noncompliance and ADRs 
Hospitals in Canada are sustaining a substantial decrease in funds due to cuts in 
health care spending (Naylor, 1999), and unnecessary hospital admissions could be 
contributing to the financial burden in Canadian hospitals. Col et al., (1990) reported that 
almost 33% of hospital patients disclosed a history of medication noncompliance; 
because this figure was obtained by self-report it is likely to be a eonservative estimate of 
noncompliance. With approximately 10% (Col et al., 1990) to 27% (Grymonpre, 
Mitenko, Sitar, & Aoki, 1988) of hospital admissions estimated to involve 
noncompliance, and 10% to 23% (Col et al., 1990; Grymonpre et al., 1988; Nolan and 
O’Mallley, 1988) of hospitalizations estimated to involve ADRs with prescription 
medication, it is clear that there may be a considerable hospitalization cost to the health 
care system when medications are not taken properly. For example. Statistics Canada 
(1997) reported a hospitalization cost of almost $26.5 billion for 1995. Applying the 
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above statistics to this example, noncompliance or ADRs could possibly have accounted 
for an estimated $13 billion health care dollars in a single year. Further, in 1994 public 
funds accounted for 85% to almost 90% of the health care budget for inpatient and acute 
care in Canada (OECD, 1996). 
Additionally, in the United States 200,000 older adults were estimated to be in the 
hospital with ADRs in 1987 and “Thirty-nine percent of all those hospitalized for drug 
reactions were elderly, according to Kusserow’s citation of the 1988 hearings on drug 
abuse in the elderly by the U.S. Senate Special Committee on Aging.” (cited in Smith et 
al., 1994). Applying a staggering average cost of $2,150 per hospital admission (Col et 
al., 1990) to this example, an estimated total of $430 billion could have been incurred for 
ADR related hospital admissions for older adults in the United States in 1987. It has been 
reported that up to 76% of older adults’ hospitalizations due to ADRs can be avoided 
(Bero, Lipton, & Bird, 1991). In this example alone, that would have been an estimated 
savings of almost $327 billion in a single year, not to mention better quality of life for 
152,000 older adults. 
When hospitalization costs are broken down into daily units, they can be quite 
high. For example, in the United States as far back as 1980 the estimated cost per day in 
the hospital was $245 (American Hospital Association, 1981). In Canada the average 
cost per day in the hospital was reported to be $514.76 in 1992 (Statistics Canada, 
1992a). The average length of stay for the general population in Canada in 1996-1997 
was 10 days (Statistics Canada, 1998a). A significant amount of hospital admissions and 
readmissions are for older adults with chronic conditions, and when older adults are 
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admitted to the hospital, they tend to stay almost twice as long as the general population, 
with an average of between 17 to 21 days (Statistics Canada, 1991). Based on the cost 
per day in 1992 in Canada (Statisties Canada, 1992a), the extra ten days spent in the 
hospital by the average older adult could cost approximately $5, 000 more per admission 
than the general population. However, older adults tend to receive less high tech and 
expensive treatment when in hospital. For example, older adults are less likely to be 
given surgeries or expensive screening tests, and are more likely to be prescribed 
medications. Therefore, the actual cost for an older adults’ longer hospital stay is likely 
less than that of young adults. 
The longer the hospital stay, and the older the patient, the more prescriptions the 
patient takes home with them on discharge (Vestal, 1990). This increases the possibility 
of more complex medication regimens, subsequent drug interactions, ADRs, and 
readmission to hospital for drug related symptoms. As a result, hospital admissions for 
older adults due to noncompliance or ADRs can serve to compound the original problem 
of medication noncompliance. It should be noted, however, that because of budget cuts, 
staff shortages, and more efficient medical treatment hospital stays are becoming shorter 
for most adults, older or younger. 
Understanding Compliance 
It must be understood that the task of compliance is not as straightforward as it 
may seem because there are many factors that can contribute to noncompliance. Before 
any attempt is made to equip older adults for medication compliance, an attempt must be 
made to simply understand the complexity of the task. 
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Although on the surface the task of remembering to take medication appears to be 
relatively simple, medication taking can be viewed as a complex memory task involving 
both cognitive and metacognitive factors. The cognitive component of compliance 
imposes a heavy memory demand which can include both prospective memory (memory 
for future events), and retrospective memory (memory for past events; Einstein & 
McDaniel, 1990; 1996; Park, 1992). The use of memory aids as a compensatory 
mechanism can help to alleviate this cognitive demand (for a review see Park & Kidder, 
1996), however the spontaneous use of memory aids by older adults to aid in medication 
compliance has only begun to be researched (Gould et al., 1997). 
Adding to this already complex task is the metacognitive component of 
medication compliance (Park & Kidder, 1996; Park, Willis, Morrow, Diehl, & Gaines, 
1994). Metacognition can include both a knowledge base (factual memory and self- 
knowledge regarding memory) and a belief base (memory self-efficacy and memory 
related affect; Hultsch, Hertzog, Dixon, & Davidson, 1988). It is thought that these 
metacognitive factors do not merely reflect one’s perception of past memory 
performance, but that metacognition impacts future memory performance (McDonald- 
Miszczak, Gould, & Tychynski, 1999). 
As people age, more chronic conditions lead to the need for more medication. 
More medication also means more complex medication regimens which create a heavier 
cognitive demand on the older adult for adherence to medication regimes. Given that 
increasing medication complexity increases the memory demand on older adults and 
complicates the metacognitive component of compliance, it is no surprise that many 
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studies demonstrate decreasing compliance with increasing regimen complexity, and that 
many older adults are turning to the use of strategies to compensate for this increased 
cognitive demand in the face of cognitive decline. 
The Cognitive Component of Compliance 
A decline in memory performance for older adults has commonly been implicated 
as one of the factors related to non-compliance with medication regimens, and medication 
compliance has often been described as a real life prospective memory task (Einstein & 
McDaniel, 1990; Gould et ah, 1997; Park & Kidder, 1996). Prospective memory is 
broadly defined as memory for future events (Einstein, & McDaniel, 1990), and 
remembering to take a medication at some specified point later in the day is clearly such a 
task. Some researchers however, have suggested that medication compliance is not 
strictly a prospective memory task, but rather a complex mixture of cognitive (Park, 
1992; Park et al., 1992) and social factors (Park & Kidder, 1996). One particularly 
important component of prospective memory performance is retrospective memory, or 
memory for past information (Einstein & McDaniel, 1990; 1996). In the case of 
medication compliance, once the specified time has arrived for the compliance task to 
occur, retrospective memory is necessary to recall the details of the medication regimen. 
Correct compliance will not have occurred, for example, if the older adult takes the 
wrong medication at the “correcf ’ time. Therefore it is important not only to consider 
prospective memory performance, but also retrospective memory performance when 
looking at the complex task of medication compliance. 
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Prospective memory. Prospective memory is memory for future events (Einstein 
& McDaniel, 1990; 1996), and in the case of medication compliance, the primary 
prospective concern is for when a medication is to be taken. An example of medication 
compliance as a prospective memory task is simply remembering to take your 
medications at a particular time later in the day, for example 4:00 p.m. The task becomes 
more demanding, however, as increasing amounts of medication are involved. Recall that 
the average older adult takes from two to four medications at any given time, and to use a 
realistic example of the prospective task of medication compliance, this must be taken 
into account. Prospective memory for such a medication regimen could involve 
remembering to take not only that medication at 4:00 p.m., but also one at 10:00 a.m., one 
at 8:00 p.m. and another one at 10:00 p.m. Clearly, there is a progressively heavier 
prospective memory demand in the task of medication compliance with increasing 
amounts of medication, and one must consider older adults’ prospective memory 
performance to understand older adults’ medication compliance. 
Prospective memory can be either time based or event based. A time based 
prospective memory task requires a person to remember to do something at a specific 
time in the future, as in the example above when a person must remember to take 
medication at 4:00 p.m. An event based prospective task involves remembering to 
perform an action when a particular event or cue occurs. For example, the person in the 
above example may go to bed every night at 10:00 p.m. The bedtime event becomes a 
memory cue for medication taking. The prospective memory task has become an event 
based rather than a time based memory task (Maylor, 1990; Park & Kidder, 1996). Time 
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based prospective tasks are thought to be more difficult than event based prospective 
tasks because they are considered to be higher in self-initiated retrieval, and therefore 
more demanding (Craik, 1986). 
It is often reported that older adults outperform younger adults on both time based 
and event based prospective memory tasks when they have employed the use of external 
memory aids. Younger adults also perform more effectively on prospective memory 
tasks (e.g,. mailing postcards at a particular time) with the use of strategies or memory 
aids (Meacham & Leiman, 1982; Meacham & Singer, 1977). However, older adults have 
consistently performed at least as well as, and most often better than, younger adults on 
the naturalistic time based task of making telephone calls at a specified time, and they 
usually report the use of strategies in aecomplishing this task (Devolder & Presley, 1992; 
Maylor, 1990; Moscovitch, 1982; Poon & Schaffer, 1982; West, 1988). Yet, Einstein, 
McDaniel, Richardson, Guynn, and Cunfer (1995) reported that older adults did not 
perform as well as younger adults on a laboratory time based prospective task without the 
use of memory cues. They did report however, that older adults performed at least as well 
as younger adults on event based prospective memory tasks in the laboratory. The 
memory cue in this task was a target word embedded in a short term memory task. 
Similarly, Einstein and McDaniel (1990) reported that older adults outperformed younger 
adults on event based prospective tasks when participants were allowed to construct and 
use a memory cue, however older adults performed as well as younger adults even 
without the use of memory aids. Yet in another laboratory setting, West (1988) found 
that younger adults performed better than older adults on event based memory tasks. The 
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authors felt that they provided a rich situational memory cue for the event based task (i.e., 
a sentence signaling the end of the interview and a folder on the desk). However this 
study was slightly different from most prospective memory studies as the cues provided 
were generated by the researcher and not by the participant, further the cues provided 
were not particularly salient cues when given in a laboratory setting. 
Lack of memory cues for time based prospective tasks have resulted in poorer 
memory performance for older adults in both naturalistic (Maylor, 1990; Moscovitch, 
1982) and laboratory (Einstein et al., 1995) settings, though not always lower 
performance than younger adults. Further, the use of memory cues has resulted in better 
performance for older adults for not only time based, but also event based memory tasks 
which already have a built in memory cue. Happily, most research suggests that with the 
use of memory cues older adults are able to perform as well as, or better than, younger 
adults on both time and event based prospective memory tasks. 
Despite this evidence that older adults can perform very well on prospective 
memory tasks, when it comes to the prospective task of medication compliance, omission 
errors (prospective memory errors) are very common. As discussed earlier, they are far 
more common than errors of commission, and this suggests that the prospective 
component of medication compliance may be especially important for older adults (Park 
et al., 1992). Further, according to the studies cited above, it is usually with the use of 
memory aids that older adults successfully outperformed younger adults on prospective 
memory tasks. Similarly, in the case of compliance with pseudo medication regimens, 
older adults have shown higher levels of compliance with training in the use memory aids 
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with a prospective component (Leirer, Morrow, Pariante, & Sheikh, 1988) and with the 
provision of telephone voice mail reminders as a prospective memory aid (Leirer, 
Morrow, Tanke, & Pariante, 1991). Further, Palmer and Dobson found that older adults 
who failed to progress in a self-medication program had received a score of zero on 
Pajurkova and Wilkins’ (1983 cited in Palmer & Dobson, 1994) prospective memory 
task. Given the improved prospective memory performance of older adults with the use 
of memory aids on naturalistic memory tasks, laboratory memory tasks, and pseudo 
medication memory tasks, older adults’ unintentional omission errors in medication 
compliance are prospective errors that can possibly be avoided simply through the use of 
effective memory aids. 
Retrospective memory. An important component of prospective memory is 
retrospective memory, or memory for past information or events (Einstein & McDaniel, 
1990; 1996; Park & Kidder, 1996). Prospective remembering to take a medication is only 
the first step, and once this is accomplished, retrospective remembering of how to take 
what amount of which medication must also occur. In our earlier example, when 4:00 
p.m. arrives, the older adult needs to remember to take two blue pills on an empty 
stomach, and to make sure s/he doesn’t eat for one hour afterwards. Of course, for the 
average older adult, s/he also needs to remember to take one pink pill, on a full stomach 
at 10:00 a.m., two yellow pills with food, but not with milk at 8:00 p.m., and one green 
pill on an empty stomach at 10:00 p.m. Further, s/he needs to remember that certain 
foods, over-the-counter medications, or even activities should be avoided with some of 
these medications. The task of compliance clearly becomes more complex with each 
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additional medication, and the cognitive demand becomes more weighty. Therefore it is 
important not only to consider older adults’ prospective but also their retrospective 
memory performance in order to understand medication compliance in this population. 
Older adults have consistently demonstrated deficits in retrospective cognitive 
performance both in the laboratory (Hultsch & Dixon, 1990; Salthouse, 1989; 1991a; 
1991b) and in the context of medication compliance (Park et al., 1994). Kausler (1989) 
argues that the type of memory task (i.e., effortful vs. automatic) and the external validity 
of the task may serve to accentuate or attenuate age differences. However, decline in 
performance has been demonstrated in a variety of areas including working memory 
(Hultsch, Hertzog, Small, McDonald-Miszczak & Dixon, 1992), operational capacity 
(similar to working memory; Salthouse & Mitchell, 1989), memory speed (Hultsch, 
Hertzog, Small, McDonald-Miszczak, & Dixon, 1992), visual memory (Isaac et al., 1993; 
Park, Smith, Morrell, Puglisi, & Dudley, 1990), recall of word lists (Devolder & Pressley, 
1992; Isaac et al., 1993; McDonald-Miszczak, Hunter, & Hultsch, 1994), digit span (Isaac 
et al., 1993), free recall (Einstein & McDaniel, 1990), recognition (Einstein & McDaniel, 
1990), face-name learning (Devolder & Pressley, 1992), recall of names and personal 
information in a social context (West & Clark, 1998), and in the retrospective component 
of prospective tasks (West, 1988). Most of this research is cross-sectional, and therefore 
it confounds age with cohort effects. The effects described above could be due to cohort 
rather than age, therefore it cannot be concluded from this researeh that retrospective 
memory ability declines with age. It is clear, however, that older adults have 
demonstrated difficulty with retrospective memory performanee. 
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The ability to reeall medication information can impact compliance behaviour, 
thus difficulty with retrospective memory performance can have a negative impact on 
medication compliance. Older adults have been reported to remember as little as 54% of 
medication instructions from their physicians immediately following their visit with the 
doctor, and 30% of patients interviewed failed to recall a newly administered medication 
despite the fact that they had the new prescription with them at the time of the interview. 
Further, 82% of these participants failed to recall instructions to discontinue medication 
during the preceding visit (Rost & Roter, 1987). Col et al., (1990) reported greater 
noncompliance with poor recall of medication regimen. Palmer and Dobson (1994) 
found that retrospective memory performance (i.e., cued recall) predicted both 
prospective and retrospective components of patients’ ability to progress in a self- 
medication program. Further, older adults have been shown to have poorer memory 
performance and poorer comprehension than younger adults for new medication 
information (Morrell, Park, & Poon, 1989; 1990), and it is the older adult who has more 
medication information to recall. 
Thus it can be seen that retrospective memory plays an important role in the 
complex task of medication compliance, and older adults consistently demonstrate lower 
cognitive performance than younger adults in this area. Unfortunately, difficulty with 
retrospective memory performance comes at a time when the cognitive demand of 
medication compliance becomes more complex with increasing amounts of medication 
being prescribed for older adults. Taking the wrong medication or not recalling 
accompanying instructions because of poor memory performance leads to unnecessary 
A Metacognitive Model 23 
noncompliance, and could render the medication therapy ineffective, or even lead to 
ADR’s or other complications resulting in costly hospitalization and negative health 
consequences. The retrospective component of medication compliance is an important 
part of the prospective task of compliance, and in light of age differences in retrospective 
memory performance for older adults, it seems fitting to consider whether aids and 
memory strategies can assist older adults in this area. 
The Role of Strategy Use in Medication Compliance 
According to Park et al., (1992) medication behaviors have not been linked 
directly to cognitive processes. However, aids to cognitive processes have been shown to 
improve compliance behaviours. Research has been conducted to determine the 
usefulness of a variety of memory aids both for memory performance in general and for 
medication compliance specifically. For certain measures of memory performance, this 
research has included contextual integration (Park et al., 1990) and various forms of 
memory training (Lachman, Weaver, Bandura, Elliott, & Lewkowicz, 1992; Stigsdotter, 
& Backman, 1989). For medication compliance, this research has included memory aids 
such as telephone voice mail reminders (Leirer, Morrow, Tanke et al., 1991), bottle cap 
alarms (Machowiak et al., 1994), organizing medication information for easier recall 
(Morrow, Leirer, Alteri, & Tanke, 1991), a variety of pill box organizers (Mackowiak et 
al., 1994; Park, Morrell, Frieske, Blackburn, & Birchmore, 1991; Park et al., 1992), 
organization charts (Park et al.„ 1992), and easy to use mnemonics for memory training 
(Leirer et al., 1988). The use of memory aids has generally been successful for improving 
memory performance both for laboratory memory tasks and for medication compliance. 
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though not all have found this relationship between compliance and the use of memory 
aids (Graveley & Oseasohn, 1991). The use of multiple memory aids has been reported to 
be more effective than the use of just one aid to improve performance for both laboratory 
memory tasks (Stigsdotter & Backman, 1989) and medication compliance (Park et al., 
1992). 
However, despite the demonstrated effectiveness of memory strategies for 
improving medication compliance, people are not likely to continue to use these strategies 
for long after the study has concluded (Comoldi, 1988; Herrmann, Rea, & Andrzejewski, 
1988). It is important to keep in mind that strategies will only be useful to older adults as 
memory aids if they are used, regardless of their effectiveness in laboratory studies. 
Mackowiak et al. (1994) reported that many volunteers who were willing to participate in 
their study changed their minds when they saw the devices to be tested. Those who did 
participate preferred the less complex devices, and the simple medication tray organizer 
was strongly preferred. However, even some of the simple medication organizers can 
prove difficult for older adults to use properly (Park et al., 1991) due to factors such as 
physical or cognitive decline (e.g., arthritis or low comprehension of medication 
regimens), especially for those taking multiple medications. 
Past studies typically assign a memory aid and test it, but very few have examined 
older adults’ real life use of memory strategies. If strategies are to be of any use, they 
must be used, and it would make sense to find out what strategies older adults are already 
using, and then to examine the role of these strategies in medication compliance. Older 
adults report that they are using memory strategies in every day life (Cavanaugh, Grady & 
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Perlmutter, 1983), however, few studies have closely examined these strategies. Those 
who have researched older adults’ use of memory strategies outside of the laboratory have 
found that older adults use external strategies for everyday memory tasks such as 
remembering routines, objects or appointments (Cavanaugh et ah, 1983; Gould et al., 
1997; Loewen, Shaw, & Craik, 1990), and internal strategies for medication memory 
tasks (Gould et al., 1997). External strategies involve making a change to the physical 
environment such as placing the pill bottle on the breakfast table, while internal strategies 
involve mental efforts to remember, such as rehearsing medication instructions in your 
head or planning to take medications when you return from an errand (Dixon & Hultsch, 
1983). Based on the reports of older adults regarding their differential use of memory 
strategies for everyday memory tasks versus medication compliance, Gould et al., (1997) 
feel that “It is possible that the type and quantity of strategies used are highly related to 
the targeted memory task.” (p. 32). 
Einstein and McDaniels (1996) believe retrospective and prospective components 
of memory to be distinct, and studies support that view through differential prediction of 
prospective and retrospective compliance (Devolder & Pressley, 1992; Gould et al., 
1997; Loewen et al., 1990; Zelinski, Gilewski, & Anthony-Bergstone, 1990). More 
difficult time based prospective tasks may be changed into event based prospective tasks 
through the use of memory strategies (Maylor, 1990). In the Gould et al. (1997) study, 
older adults reported using both retrospective and prospective strategies for medication 
compliance. Strategies used regularly by over half of the sample included the external 
prospective strategy of leaving pills in a prominent place, internal prospective strategies 
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of relating pill taking time to usual activities, planning (in the morning) the medication 
regimen around the activities of the day, internal retrospective strategies of re-reading 
instructions to increase recall, re-reading very slowly, mentally repeating instructions, 
concentrating hard on verbal instructions, trying hard to learn the amounts, and trying 
hard to learn the times. 
It is clear that memory strategies are effective compensatory tools, and it is known 
that older adults report the use of a variety of strategies outside of the laboratory for 
medication compliance. However, it is also known that compliance with medication 
regimens remains low, and that older adults are at risk for the negative effects of 
noncompliance. There is a piece missing - why is low compliance such a widespread 
problem when studies show that older adults report the use of effective memory 
strategies? It is interesting that older adults often don’t continue to use memory 
strategies learned in a laboratory situation despite the fact that they are demonstrated to be 
effective aids. Obviously, factors other than objective improvement in cognitive 
performance are operating when older adults choose to use or to not use memory 
strategies for medication compliance. It would be helpful to know under what conditions 
older adults decide to use strategies to aid their compliance. In a recent study, Gould et 
al. (1997) used multiple regression to predict the use of strategies from a variety of 
variables, and reported that metamemorial factors predicted not only the use of strategies 
but also self-reported medication compliance. 
The Metacognitive Component of Compliance 
It is important to consider the role of metamemory in medication compliance for 
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two reasons. First, if medieation compliance has a weighty cognitive component as 
described earlier, then it is important to examine metaeognitive faetors as metamemory is 
believed not only to reflect past cognitive performance, but also to affect future cognitive 
performance (Dixon & Hultsch, 1983a; Gould et al., 1997; McDonald-Miszczak et ah, 
1999). This means that metamemory may impaet the cognitive performance of older 
adults for the prospective task of medication compliance. Second, metamemorial factors 
may influence an individual’s choice to use or to not use effective strategies (Mazzoni, 
Comoldi, Tomat, & Vecchi, 1997) as a compensatory aid for the task of medication 
compliance (Gould et al., 1997). Understanding the role of metamemory in the choice of 
strategies may help to clarify more about the complex task of medication compliance. 
Metamemory is not memory, rather it is about memory; it has been very generally 
defined as “cognitions about memory” or “thinking about remembering” (Hertzog, Dixon, 
& Hultsch, 1990a; Hultsch et al., 1988). More specifically, metamemory can be defined 
as one’s knowledge, affect, and beliefs about their own memory and about human 
memory systems (Dixon, 1989). Like compliance, metamemory is complex and 
metamemory is best considered a “multidimensional construcf ’ (Dixon & Hultsch, 
1983b; Hultsch et al., 1988). Metamemory consists of many different theoretical 
dimensions including 1) knowledge of basic human memory processes, 2) the perception 
of one’s personal motivation to achieve a memory task, 3) the knowledge and self- 
reported use of memory strategies, 4) beliefs about one’s own memory capacities, 5) 
perceived change in personal memory function, 6) locus of control regarding memory 
skills, 7) and anxiety regarding personal memory performanee (Dixon & Hultsch, 1983a; 
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1983b; Dixon, Hultsch, & Hertzog, 1988; Hertzog, Hultsch, & Dixon, 1989). These 
dimensions are distinct, and each of these dimensions has demonstrated some degree of 
correlation with memory performance measures; correlations are generally only modest 
which is not surprising given the multidimensional nature of the construct (Dixon, 1989; 
Shlechter, Herrmann, & Toglia, 1990). Metamemory can be effectively conceptualized as 
having two broad dimensions including a knowledge base (factual memory and self- 
knowledge regarding memory) and a belief base (memory self-efficacy and memory 
related affect; Hultsch et al., 1988). 
Metacognitive models describe the way in which metacognitive factors influence 
cognitive performance, and these models can be very simple or very complex. For 
example, Cavanaugh (1989) presents a complex metacognitive model which in part 
predicts that metacognitive beliefs impact performance through outcome expectation, 
effort and strategy selection. A less complex model would predict that self-efficacy 
(which is influenced by past performance) impacts future performance through strategy 
use. In each model, metacognitive beliefs influence cognitive performance through the 
use of strategies. There are no metacognitive models however, which deal specifically 
with the task of medication compliance. 
It is important to note that medication compliance is not strictly a measure of 
cognitive performance, but it is also a health behaviour. Indeed, Park et al., (1994) 
suggest that as compliance becomes more understood, more sophisticated models of 
health behaviour should evolve. The Health Belief Model (Rosenstock, 1974) is a 
comprehensive model developed to examine the role of individuals’ beliefs in 
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preventative health behaviour, yet it is not readily adaptable to medication compliance 
(Kasl, 1974). Older adults’ medication is usually prescribed for diagnosed chronic 
conditions, and therefore such compliance is not considered to be preventative health 
behaviour. Despite this limitation, the Health Belief Model does provide a framework 
and history of research with extensive support for the importance of beliefs in health 
behaviours (Rosenstock, 1990). The key components of the health belief model include 
the individual’s perception of threat (of personal susceptibility to an illness and of 
severity of the illness), one’s outcome expectations (perceived benefits of action less 
perceived barriers to that action), and self-efficacy regarding one’s ability to carry out the 
action necessary to avoid the illness (Rosentstock, 1990). Although the focus of this 
paper is on the cognitive and metacogntive components of compliance, it is important to 
remember that medication compliance is neither strictly cognitive performance, nor is it 
strictly a health behaviour, rather it is a hybrid between the two. Moreover both the 
metacognitive models and the health belief model provide evidence that beliefs are an 
important component of both aspects of compliance. 
Certainly, the Health Belief Model has been tested over many years with a wide 
variety of health behaviours including medication compliance (e.g., antipsychotic 
medication; Budd, Hughes, & Smith, 1996), compliance with weight loss or exercise 
regimens (Becker, Maiman, Kirscht, Haefner, Drachman, & Taylor, 1979), preventative 
diet, exercise, and smoking behaviour, attendance to various screening programs, as well 
as breast-self-examinations - and beliefs have proven to be an important factor in 
individuals’ health behaviours (for a review see Becker, 1974; Janz & Becker, 1984) 
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though this relationship is not always found (Becker et ah, 1979). Further, in keeping 
with the metacognitive models, medication compliance and other forms of memory 
performance and adaptive memory behaviours have been shown to be affected by many 
metacognitive factors such as motivation to comply (Janz & Becker, 1984), commitment 
(Putnam, Finney, Barkley, & Bonner, 1994), the belief that compliance is important 
(Gould et al., 1997; Lorenc & Branthwaite, 1993), concern about health matters in 
general, fear of medication addiction (Lorenc & Branthwaite, 1993), the perceived 
seriousness of memory failure or memory problems (Dobbs & Rule, 1987; Zelinski, 
Gilewski, & Anthony-Bergstone, 1990), general attitudes about beliefs and memory such 
as memory anxiety (Gould et al., 1997) and memory self-efficacy (Gould et al., 1997; 
McDonald-Miszczak et al., 1994; Zelinski et al., 1990), and attributions of control 
(Devolder & Pressley, 1992; McDonald-Miszczak et al., 1999; Robinson-Whelen & 
Storandt, 1992). Further, metacognitive variables can also influence compliance 
indirectly through other metacognitive variables such as when “motivation.../w/z/c/z 
affects performance] .AS influenced by beliefs about the value of the treatment and about 
one’s ability to perform the task (Janz & Beeker, 1984)” (cited in Park et al., 1994, p. 41). 
Similarly, Mueller, Johnson, Dandoy and Keller (1992) reported that the self concept can 
serve as a mneumonic aid to memory performance. 
Metamemorial beliefs are relatively stable over time despite changes in actual 
memory performance (McDonald-Miszczak, Hertzog, & Hultsch, 1995). However, 
direct intervention with metamemory can improve older adults’ beliefs that they can 
control their memory change and that ability can improve with effort, and such 
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intervention can contribute to more positive beliefs regarding current memory abilities 
(Lachman, Weaver, Bandura, Elliott, & Lewkowicz, 1992). This is important in light of 
the fact that metamemorial beliefs can impact future memory performance. 
Just as it was necessary to examine how older adults perform cognitively to 
understand the task of compliance for older adults, it is also important to examine the 
metamemorial knowledge and beliefs of older adults in order to understand the role of 
metamemory in compliance for this population. The patterns of metamemory are 
different for older adults than for younger adults, and so the relationship of older adults’ 
metamemory to actual memory performance may also be unique. For example, 
McDonald-Miszczak, Hertzog and Hultsch (1995) reported that as memory performance 
declined in older adults. Memory Self Efficacy (MSE) decreased while memory anxiety 
and external strategy use increased. 
Older adults report more memory problems than young adults (Dobbs & Rule, 
1987), are more likely to use external memory aids (Hultsch, Hertzog, & Dixon, 1987; 
Loewen et al., 1990), are more likely to be upset by memory failure (Cavanaugh et al., 
1983), report lower memory capacity (beliefs about memory ability) (Hultsch et al., 1987; 
Loewen et al., 1990), more decline in memory function, and a more external locus of 
control. Yet those older adults who believe memory performance to be due to 
controllable factors demonstrate better memory performance (Devolder & Pressley, 
1992). Older adults have reported that it is more important to remember the amount than 
the time to take a medication, and that side effect information is just as important as 
either amount or time (Gould et al., 1997). Compared to younger adults, older adults tend 
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to be more accurate in predicting their own memory performance (Hertzog, Dixon, & 
Hultsch, 1990; McDonald-Miszczak et ah, 1994), and are more likely to improve their 
prediction accuracy with experience (McDonald-Miszczak, Hubley, & Hultsch, 1996). 
Older adults’ MSE guides performance predictions until task specific experience is 
gained, and then this task specific experience guides predictions of memory performance 
(Hertzog, Dixon, & Hultsch, 1990b; McDonald-Miszczak et ah, 1994). Hertzog, Dixon, 
& Hultsch, (1990b) suggest that their results support the hypothesis that MSE beliefs are 
partially based on actual memory performance, and that age differences in memory 
predictions may be mediated by differences in MSE. Older adults’ performance may be 
more related to their beliefs about MSE than younger adults (Hultsch et al., 1988). This 
makes metacognition an important issue to consider when examining medication 
compliance in older adults. 
Unfortunately, older adults’ metacogntive beliefs are quite often negative, and 
these beliefs can impact their memory performance, including their medication 
compliance. Fortunately, these beliefs can be improved with intervention (Lachman et 
al., 1992). Since beliefs have been shown to impact both cognitive performance and 
health behaviours, and since medication compliance is a hybrid of a health behaviour and 
of cognitive performance, it is apparent that medication compliance may be susceptible to 
the influence of an individual’s beliefs. The success of the health belief model in 
predicting health behaviours and the evidence supporting metacognitive models suggest 
that it is time for a metacognitive model that deals specifically with the health behaviour 
of medication compliance. This will open the door for an intervention paradigm focused 
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on older adults’ metacogntive beliefs, and it may prove to be an effective tool for aiding 
older adults in their medication compliance. 
Measuring Compliance 
Compliance cannot be studied without first being measured, and the method of 
measurement chosen affects any conclusions that can be drawn about compliance. A 
compliance measure should be one that can be compared to past research, and one that is 
appropriate to the particular goals of the individual investigation (Sackett, 1979). 
Recently, Cramer and Rosenheck (1998) reviewed over 20 years of research in order to 
compare compliance rates between physical and mental disorders. Compliance with 
medications for physical disorders was measured using microelectronic monitoring with a 
mean compliance rate of 76% (SD=10; with means ranging from 60-92%). Compliance 
with antidepressant and antipsychotic medications was measured using a variety of 
methods including clinician’s judgement (M=72%; SD=20, range 33-90%), a 
combination of either pill counts or blood levels along with self-report (M=63%; 
SD=18%, range 40-90%), urine tests (M=60%; SD=18, range 35-88%), and patient self- 
report (M=52%; SD==17%; range 24 - 87%). Two meta-analyses (Goodwin & Jamison, 
1990; Montgomery et al., 1995) revealed compliance rates of 66% and 79% respectively. 
Considering all measures of compliance together, the overall rate of compliance with 
antipsychotic medications was 58%. Unfortunately, they did not extend their research to 
cover similar methods of compliance measurement in physical disorders, nor could they 
find compliance research using microelectronic monitoring for mental disorders. 
However, their research does provide an overview of a wide range of compliance rates 
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found with a variety of measurement methods, and highlights the importance of careful 
consideration when choosing a method of measurement. 
There are many ways to measure medication compliance and these methods differ 
in terms of accuracy, accessibility, cost, and ecological validity. Measures of compliance 
can be either direct or indirect (Boczowski & Zeichner, 1985). Direct measures of 
compliance assess drug levels in the body, while indirect methods do not confirm whether 
or not drugs have actually been ingested. This category of measurement includes a 
variety of measures such as checking on prescription refills, pill counts, measurement of 
therapeutic effect, clinician judgement, bar code technology, MEMS (a medication event 
monitoring system), and patient self-reports. Some indirect methods (such as MEMS) are 
highly accurate but are very costly and inaccessible, therefore such methods of 
measurement are often restricted to research situations and have very little ecological 
validity. At the other extreme are measures (such as the self-report) that are inexpensive, 
very accessible, and high in ecological validity, but often inaccurate. Each method of 
measurement carries with it some drawbacks, and it is important to consider these 
drawbacks when choosing a method of measuring compliance. 
Direct Measures of Compliance 
Biologic assays of active drug or metabolite (e.g., biological markers in urine or 
blood levels) are often very costly and usually not very practical for the purposes of most 
compliance studies (Babiker, Cooke, & Gillett, 1989). Drug assays can be affected by 
factors other than compliance, such as the presence of other medications, individual 
differences in metabolism of drugs, and long-lasting and possibly cumulative effects of 
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other drugs. Further, these drug assays are measures of compliance at only one particular 
point in time (Babiker et al., 1989; Dubbert et al., 1985; Rudd, 1993), and this one 
instance may not be (in fact is unlikely to be) representative of an individual’s overall 
compliance with their medication regimen. When drug assays are used, compliance may 
be more likely because the individual knows they will be seeing their doctor and this 
serves as a memory cue for them to take their medication. Further, if an individual knows 
s/he will be tested, s/he may be motivated to comply previous to the appointment so that 
s/he will appear compliant in general. Because these methods are not readily available, 
are not necessarily accurate, and reflect atypical instances of compliance, other methods 
of compliance measurement have been examined. 
One alternate method of measuring compliance is through the detection of a 
tracer, or an alternate substance added to a medication or ingested along with a 
medication. As far back as 1959 Hobby and Deuschle reported riboflavin to be an ideal 
tracer, and although there are other tracers available, riboflavin has received much 
attention in the literature. Hobby and Deuschle considered riboflavin to be “safe, 
nontoxic, nonallergenic, cheap, palatable, stable under normal conditions, readily 
absorbed when taken orally, readily excreted in the urine, and easily detected at a low 
concentration.” Riboflavin shows up in the urine as a flourescent yellow, and various 
amounts (as low as 25 mg) are easily detected from two to eight hours post ingestion with 
a high degree of accuracy by inexperienced observers using a matching to sample method 
which requires very little equipment (Dubbert et al., 1985). This makes the riboflavin 
method accessible and quite accurate under certain conditions, and therefore it is an 
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important method to consider for compliance measurement. 
Babiker et al., (1989) conducted a series of experiments using riboflavin and 
reported that although the use of riboflavin as a tracer is very effective for single 50-mg 
doses, more frequent doses render riboflavin an unreliable tracer. They attribute this to a 
“spillover” effect due to incomplete elimination of previous doses of riboflavin by the 
time the next dose is to be measured. This is important because many older adults require 
their medications two and three times per day rather than one time per day. In Babiker et 
al.’s (1989) study, when doses were taken two and three times daily, pre-dose urine 
samples contained levels of riboflavin that were so high they could not be distinguished 
from post-dose levels. Because a tracer method like this is a measure of only one 
instance of compliance, reliability is extremely important. 
Although tracing as a measure of compliance can be very accurate in laboratory 
situations involving relatively large, single doses of riboflavin, this method of measuring 
compliance in the real world or in long term studies is not feasible. Older adults often 
take more than one dose of multiple medications in a single day, so using a tracer for each 
medication would be unrealistic, and would provide unreliable measures of compliance. 
Direct measures of compliance examine only a discreet instance rather than a pattern of 
compliance, and even when they are highly accurate, they reveal very little about an 
individual’s compliance with medication instructions. When looking at the issue of 
compliance in older adults, as is the case with many health related behaviours, any single 
instance of a health behaviour such as compliance is of little importance when compared 
to the patterns of behaviour over time. Direct measures of compliance are not able to 
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assess patterns of behaviour, and may refleet unusual instances of compliance, therefore 
indirect methods of measurement must also be considered. 
Indirect Measures of Compliance 
Checking on prescription refills can be used to measure compliance, however 
people don’t always fill their prescription at the same pharmacy; many people use more 
than one pharmacy because of convenience of location or cost. Also, those who have 
medication coverage may be more likely to fill prescriptions they won’t use than those 
who must pay for their medications out-of-pocket. Further, when checking on 
prescription refills it is not known whether or not a person actually ingested their 
medication, only that the prescription was filled. Prescription refills are, therefore, not an 
accurate reflection of actual compliance. This method of compliance measurement would 
require keeping track of each pharmacy that a person uses, and this would often rely on 
self-report of pharmacy use. Since this method relies on self-report of pharmacy use, and 
because once the pharmacies are located there is no way of knowing whether or not the 
medications are ever ingested when a prescription is filled, it would make more sense to 
use patient self-report to measure compliance directly. This method of measurement may 
be useful however, in situations where older adults live in a home with an in-house 
pharmacy. 
Pill counts are a little more ecologically valid because a physician is more likely 
to conduct a pill count than to research their patients’ use of pharmacies. However, pill 
counts are often inaccurate and they can be labour intensive if they are conducted in the 
patients home. Pill counts can be conducted in the physicians office, yet these pill counts 
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are usually anticipated by the patient, and this factor can change patterns of compliance 
prior to the appointment as when using direct measures of compliance, and this will result 
in less accurate measures of compliance. Patients may count out the correct number of 
pills and dump the rest so that they appear compliant. “Further, pillcounts must assume 
uniform pill-taking between assessments; therefore, this method also relies on self- 
reports.” (Lipton & Bird, 1994). 
Therapeutic effect of the medication may also be used to measure compliance, and 
this method is more ecologically valid than both checking on prescription refills and pill 
counts because physicians frequently use this information to determine not only 
compliance with medication but also the effectiveness of a prescribed medication. 
However, using the therapeutic effect of a medication to measure compliance is 
problematic not only because therapeutic results may occur without full compliance, but 
also because therapeutic effect itself needs to be monitored in patients independently of 
compliance. It may be that an individual doesn’t need their full prescription, but using 
therapeutic effect as a tool to measure both medication effectiveness and compliance will 
mask the fact that less medication is needed. This won’t be discovered because 
therapeutic effects are achieved and the prescription is continued at the current level. 
In such a scenario, it is tempting to assume that clinicians know their patients well 
enough to correctly estimate their compliance with prescribed regimens. If this were the 
case, then physicians could use their judgement to determine whether or not a patient is 
complying to their medications, and then use therapeutic effect to determine the 
effectiveness of this compliance. Unfortunately, a physicians guess is only as good as 
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anybody else’s when it comes to determining levels of compliance in other people 
(Gordis, 1979). Hence another ecologically valid measure of compliance is needed, and 
such a measure will be discussed after consideration of what technology can contribute to 
the measurement of medication compliance. 
Technology and compliance measurement. Technology has provided indirect 
methods of measuring compliance that can be quite accurate, however these methods can 
also be quite intrusive or expensive (Park et al., 1994). Bar code technology has provided 
such a measure that is quite accurate, yet very intrusive to the patient. Further, bar code 
systems such as The Videx Time Wand System are not ecologically valid measures 
because they are generally used only in research situations, and not in actual compliance 
situations outside the laboratory. Indeed, this method of measuring compliance changes 
the task of compliance with medication to a task of compliance with medications plus 
compliance with the compliance measure. This method requires the patient to scan a bar 
code corresponding to the correct medication every time a medication is taken. The Videx 
Time Wand System uses a credit card sized scanner and electronic bar code card 
technology. Bar codes are given to subjects for each of their medications, and these are 
put into a wallet. The Wands need to be recharged every week, but the only cost is the 
initial purchase of the wand and the downloading software. 
A simpler solution using technology to measure compliance is the Medication 
Event Monitoring System (MEMS). Rates of adherence appear to be similar across both 
types of technology, and they are both sensitive to interventions (Park et al., 1994). 
MEMS is an indirect method which involves placing a microchip in bottle caps, and the 
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date and time is automatically recorded each time the cap is opened. MEMS is not 
obtrusive to the patient in any way, and the batteries need not be replaced for months. 
MEMS pin points the date and time accurately every single time a bottle of medication is 
opened. 
MEMS can be considered the gold standard regarding accurate measurement of 
compliance with medications. Yet even with this status, there are drawbacks to the 
MEMS method of measurement. First, there is no way of measuring how many pills are 
taken out of the medication bottle each time, and older adults often take multiple doses of 
a medication at one time. Although it is known wether or not medication was taken at the 
correct time, it is not known wether or not the correct dose was ingested. Another very 
important drawback is that MEMS does not allow for certain types of strategy use which 
are useful in aiding older adults in the complex task of compliance. Research has shown 
that older adults perform better when they are able to use strategies such as counting pills, 
using organizer trays, and taking the pills out ahead of time and placing them in a 
prominent place. A measure of compliance, no matter how accurate, is not useful if it 
interferes with the task of compliance in anyway. Finally, a third drawback to using 
MEMS to measure compliance is the prohibitive cost. A recharge is needed every five 
months, and they carry a very costly monthly rental charge (Park et al., 1994). As a result, 
MEMS is not accessible and cannot be used except in high budget research programs. 
The cost limits MEMS to the role of an elite laboratory research tool, and keeps the tool 
out of the hands of physicians who assess real life compliance and act on these 
assessments every day. 
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Even with the contributions technology has made to the measurement of 
compliance, efficient measurement continues to be elusive. A measure of compliance 
needs to be assessable, ecologically valid, and feasible for use where such measures are 
needed frequently. To find such a measure, it would be wise to turn to the place where 
compliance information is gathered and used on a daily basis: the physicians office. 
Clinicians frequently use patients’ self-reports of compliance to measure compliance and 
alter regimens. However, the relationship between oft’ used self-reported compliance and 
MEMS (the gold standard for accurate measurement of compliance) is very inconsistent. 
Self-reports of compliance. Why would such a commonly used measure have 
such an inconsistent relationship with the gold standard of compliance measurement? 
Self-reports of compliance have been defined as domain specific metamemorial 
judgements (Gould et al., 1997), and the self-report is a complex mixture of beliefs and 
objective factors (McDonald-Miszczak et al., 1999). Thus, while MEMS measures 
compliance alone, the self-report is not only a measure of compliance, but also a 
metamemorial judgement. Perhaps the complexity of the self-report contributes to this 
inconsistent relationship, as self-reported compliance is a more dynamic measure than 
MEMS. Compliance itself is neither simple nor straightforward, and the self-report 
reflects this fact. 
Laboratory tasks have been found not to be correlated to self-reports of memory 
(Sunderland, Harris, & Baddeley, 1983), however self-reports have been related to 
everyday intelligence (Cornelius, 1990), and self-reports of compliance at 6 months and 
42 months predicted controlled blood pressure at both 2 years and 5 years (Morisky, 
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Green & Levine, 1986). Gould and her colleagues (1997) proposed that self-reports of 
compliance are a potential source of significant practical and theoretical value, over and 
above their objective accuracy as measures of compliance. Further, self-reports are the 
foremost means of data collection currently used in the social sciences (Cavanaugh, 
1999). 
Despite this, self-reports of compliance tend to be overestimated (Graveley & 
Oseasohn, 1991; Isaac et al., 1993; Putnam et al., 1994; Rudd, 1993) and are often 
considered problematic measures of compliance (Park & Kidder, 1996). However, those 
self-reports which describe an individual as noncompliant are reliable (Gordis, 1979), and 
this quick and simple method can help to positively identify a set of older adults who 
would be most likely to benefit from effective intervention. In fact, people who identify 
themselves as noncompliant may be more likely to benefit from interventions than those 
noncompliant individuals who do not identify themselves as noncompliant (Gordis, 1979; 
Rudd, 1993). Using the self-report can quickly identify a subset of noncompliant 
individuals with minimal use of resources for measurement, and can ensure that 
interventions are targeted to a population where they will be most effective. This can free 
up resources to pursue other means of assessing and aiding noncompliant older adults 
who do not identify themselves through self-reports. 
Unlike biologic assays, self-reports of compliance are not restricted to measuring 
a discreet event, rather they can be used to measure a pattern of compliance over time. 
And it is the long term pattern of compliance that is important, rather than the discreet 
event, as is the case with many health behaviours (Gordis, 1979; Rudd, 1993). 
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Further, the self-report has certain advantages when compared to checking on 
prescription refills. Checking on whether or not a prescription has been filled relies on 
the patient’s self-report of pharmacy use, and it does not give any information about 
actual ingestion of medications. When checking on prescription refills, all that is known 
is that the medication has been purchased. This method relies on self-reports to obtain 
only partial information, while self-reports of medication compliance have the advantage 
of targeting the ingestion of medications, and not just whether or not a medication has 
been obtained. 
Surprise pill counts can be a relatively accurate measure of compliance, however 
most pill counts are anticipated. Surprise pill counts are time consuming and therefore 
costly when conducted in the patients’ home, yet when patients are asked to bring their 
medications into the physician’s office for a “brown bag” visit, the patient knows that 
their compliance will be assessed. This knowledge often motivates patients to alter the 
contents of their medication bottles to reflect better compliance than has actually 
occurred. In a sense, the pill count in the physician’s office becomes a self-report yet is 
incorrectly considered a more objective measure of compliance. 
While the use of the Videx Time Wand System or MEMS to measure medication 
compliance would likely give the most accurate measures of compliance, they too have 
drawbacks (such as prohibitive cost and patient intrusiveness) that render them 
inappropriate for use in the “real world” to measure compliance. Self-reports have been 
used as long as medication has been prescribed, and despite advances in technology they 
continue to be one of the most common means of assessing medication compliance by 
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physicians today. 
Self-reports are often the most practical means of measuring compliance due to 
time and cost restrictions, and are routinely used as a compliance measure outside of the 
laboratory. Self-reported compliance is the most ecologically valid compliance measure 
available: doctors do not prescribe MEMS caps, they do not take biologic assays to check 
on compliance in most cases, and they only occasionally conduct pill counts. However, it 
is routine for physicians to ask their patients to give a self-report of their medication 
compliance, and self-reports are also used by older adults to monitor and maintain 
compliance with their complex medication regimens. For example, if an older adult 
believes that she has already taken her medication, she will not take it “again.” If this 
belief was inaccurate, then the older adult has mistakenly been noncompliant with 
prescribed medication as the result of a self-report of compliance. Many important 
decisions are based on self-reports of compliance, therefore it is important to gain an 
understanding of this frequently used measure of older adults’ compliance in order to 
increase it’s effectiveness as a compliance measure. 
Like every other method of measuring compliance the self-report has drawbacks, 
the primary drawback being lack of absolute accuracy. Improving the accuracy of an 
ecologically valid measure such as the self-report would seem to be an important 
alternative to settling on any of the presently available measures of compliance. 
Attempting to increase the ecological validity of a more accurate measure such as MEMS 
or bar code technology is another option worthy of research, but the cost remains 
prohibitive for many laboratories and the measures are either overly intrusive or 
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inaccessible at this time. Consequently, it would be wise to increase the accuracy of an 
inexpensive, aceessible, unintrusive and ecologically valid measure that is routinely used 
by physicians, pharmacists and older adults. Hence, one of the goals of this study was to 
increase the objectivity of the self-report through more focused questioning. 
Our attempt to increase the accuracy of self-reported compliance can best be 
understood by examining the meaning of accuracy with respect to self-reported health 
measures. Perceived health does not aceurately measure an individual’s health, but it 
reflects some of the objective aspects of health and these self-reports are often used to 
indicate health (Greiner, Snowdon, & Greiner, 1996; McCrae, Bartone, & Costa, 1976; 
Wenglert & Rosen, 1995). If a self-rating of health is correlated with objective factors, 
then the rating is considered to be more reflective of actual health, or is considered to be 
more accurate. In the same way, self-reports of medication compliance may not 
accurately measure one’s compliance, but if self-reports reflect the objective components 
of compliance, then they may be considered to more accurately reflect compliance. 
Therefore for the purposes of this study accuracy will be defined as a reflection of 
objective factors. 
Focused questioning may decrease some of the complexity that leads to 
inaccuracy in self-reports of compliance by focusing the patient on the objective 
components of compliance for each medication separately. Indeed, recall tasks are often 
simpler when they are broken down (Cavanaugh, 1999). As a result, self-reported 
compliance measured in a more focused manner by asking more specific questions may 
reflect more of the objective aspects of compliance, and self-reports could therefore be 
A Metacognitive Model 46 
considered more accurate. In order to facilitate more objective self-reports of 
compliance, the questions used to measure compliance should be aimed at the important 
objective components of the compliance task rather than subjective judgements. 
Self-reports of compliance have been used in numerous studies throughout the 
compliance literature, and these measures have been comprised of one or two question 
interviews (Becker et al., 1979; Col et al., 1990; Opdycke et al., 1992; Ostrom, 
Hammarlund, Christensen, Plein, & Kethley, 1985), four or five question instruments 
(Gould et al., 1997; Lipton & Bird, 1994; Morisky, Green, & Levine, 1986), and multiple 
question comprehensive medication assessments (Pesznecker, Patsdaughter, Moody, & 
Albert, 1990). The use of such a variety of self-report measures makes it difficult to draw 
firm conclusions from the literature. Additionally, many studies do not even indicate the 
nature or number of self-report items used to measure compliance in their research 
(Bernstein et al., 1989; Conn et al., 1991; Graveley & Oseasohn, 1991; Isaac et al., 1993; 
Putnam et al., 1994; Valenstein, Barry, Blow, Copeland, & Ullman, 1998). Some of 
these studies have measured compliance with medications in general (Becker et al., 1979; 
Gould et al., 1997; Morisky, Green, & Levine, 1986; Opdycke et al., 1992), and others 
have inquired about each medication separately (Darnell et al., 1986; Lipton & Bird, 
1994; Ostrom, Hammarlund, Christensen, Plein, & Kethley, 1985). 
Although there are a number of measures of self-reported compliance, many of 
these measures are flawed. Single question measures are not very reliable, and multiple 
question inventories are not very practical for everyday use in a busy physicians office or 
pharmacy. Further, older adults are not likely to sit down and administer themselves a 
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large questionnaire to improve their compliance, but they are more likely to focus on a 
few important aspects of their compliance and update themselves on their performance. A 
good self-report measure of compliance would focus on a few important, objective 
aspects of compliance (Gould et af, 1997; Morrow, Leirer, Altieri, & Tanke, 1991), and 
consider each medication separately as individuals may have different levels of 
compliance with different medications for a variety of reasons (Rudd, 1993). Lipton & 
Bird (1994) approached self-reported compliance measurement in this manner and found 
that their self-report instrument was sensitive to intervention effects. Gould et al. (1997) 
developed a medication questionnaire which focused on the important aspects of 
compliance (Morrow et al., 1991), however they did not consider each medication 
separately, and compliance was predicted by subjective rather than objective factors. 
Perhaps the use of this questionnaire in a more focused manner would yield different 
results, tying self-reported compliance to more objective factors, and therefore presenting 
a more “accurate” picture of compliance. 
Chapter Two: The Present Study 
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The Present Study 
The purpose of the present study is threefold. First, the study will attempt to 
replicate Gould et al.’s (1997) research on older adults’ use of memory strategies to aid 
medication compliance. Second, the present research will extend the research of Gould et 
al. (1997) by examining a number of different factors ranging from objective assessments 
of health to belief laden assessments of one’s memory ability. These factors will be 
investigated for ability to predict compliance using a more focused version of the Gould 
et al. (1997) self-report measure. Finally, a metacognitive model of self-reported 
compliance will be tested. 
Description and Prediction of Strategy Use 
It is important to understand strategy use in order to learn more about medication 
compliance in older adults. Medication compliance has been described as a complex task 
which makes heavy demands on one’s memory (Einstein & McDaniel, 1996; Gould et 
al., 1997; Park, 1992; Park et al., 1992; Park et al., 1994), and memory strategies are 
often used by older adults to aid them in this task (Cavanaugh et al., 1983; Gould et al., 
1997). The use of strategies by older adults has proven to be an effective tool for memory 
tasks including the task of medication compliance (Devolder & Presley, 1992; Einstein & 
McDaniel; 1990; Leirer et al., 1988; Leirer, Morrow, Tanke et al., 1991; Maylor, 1990; 
Park et al., 1994; Stigsdotter & Backman, 1989; West 1988). 
The present study attempts to replicate Gould and her colleagues’ (1997) 
investigation of the strategies that older adults use for medication compliance. The 
primary goal of Gould et al.’s (1997) study was to investigate older adults’ use of 
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memory strategies for their medications. A second goal was to identity factors that 
predicted the use of memory strategies and self-reported compliance. The predictors 
used for these analyses included a variety of metamemorial factors as well as medication 
and medical factors. 
Gould et al. (1997) used multiple regression to analyze data from fifty one adults 
over the age of 65 who were taking at least one prescription medication. The package 
completed by these adults included a personal information questionnaire, a medication 
questionnaire to measure self-reported compliance and the perceived importance of 
compliance, Prospective Memory for Medication Questionnaire (PMMQ), the 
Metamemory in Adulthood Questionnaire (MIA), and the Center for Epidemiologic 
Studies Depression Scale (CES-D). Pharmacists’ ratings of the seriousness and 
discomfort for participants’ medical conditions were also obtained for each medication. 
Self-reported compliance was a general measure in this study, and asked each of the five 
compliance and importance of compliance questions only once. 
Gould et al. (1997) found that older adults reported using internal strategies as 
memory aids for medication taking, but external strategies for everyday events. The 
authors also found that neither medication variables nor strategy use variables 
significantly predicted self-reported compliance; however, metamemorial variables 
(memory self-efficacy and memory anxiety) did significantly predict both self-reported 
compliance and the use of memory strategies to aid compliance. Further, the importance 
older adults placed on compliance also predicted the use of memory strategies. The 
authors concluded that with respect to medication compliance older adults rely, to a great 
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extent, on general beliefs regarding memory rather than on more objective health factors 
when they choose to use memory strategies, and that this seems to be mediated by the 
importance older adults place on adherence (Gould et ah, 1997). 
Like the Gould et al. (1997) study, the present investigation uses the Prospective 
Memory for Medication Questionnaire (PMMQ) to measure older adults’ use of strategies 
to aid compliance. In addition, many of the same predictor variables (i.e., medical 
variables, importance of compliance, and memory belief variables) that were used in the 
Gould study will also be used to predict strategy use in the present study. However, the 
present study includes an additional measure (memory ability) that was overlooked in the 
previous work. The memory tasks in the present study were chosen to represent memory 
abilities relevant to medication taking, and these tasks will be described in detail in the 
method section of this paper. The addition of a memory performance variable may 
reveal important information about older adults’ use of memory strategies for medication 
compliance. As demonstrated in the Gould et al. research, older adults’ decisions to use 
strategies as a memory aid for the cognitive task of medication compliance may be based 
on belief related factors, such as beliefs about memory ability. However, such decisions 
may also be based on more objective factors such as actual memory ability. The 
inclusion of both objective and subjective factors as possible predictors of strategy use 
will allow us to learn more about what motivates older adults to use strategies for 
medication compliance. 
Given the range of predictor variables included in the present study, two possible 
outcomes were proposed. The first outcome would be a replication of the Gould et al. 
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(1997) study in which two belief laden variables, the perceived importance of compliance 
and memory beliefs, predict strategy use. This would suggest that older adults base their 
decision to use strategies on subjective belief related factors (Gould et ah, 1997; Lorenc 
& Branthwaite, 1993). For example, an older adult may choose to use memory strategies 
because they believe that they have a poor memory, or because they believe that they will 
not be able to remember a specific memory task, such as compliance, without the help of 
strategies. Further, if an individual believes that compliance with a particular medication 
is important to her health or quality of life, she may be more likely to use memory 
strategies to ensure that the important task is not forgotten. 
Because research has demonstrated a relationship between strategy use and 
memory performance (Lachman, Weaver, Bandura, Elliott, & Lewkowicz, 1992; Leirer, 
Alteri, & Tanke, 1991; Leirer et al., 1988; Leirer, Morrow, Tanke et al., 1991; Lorenc & 
Branthwaite, 1993; Machowiak et al., 1994; Park et al., 1991; Park et al., 1992; Park et 
al., 1990; Stigsdotter, & Backman, 1989), the second possible scenario was that strategy 
use would be predicted by actual memory performance. This scenario would suggest that 
older adults base their decisions to use strategies on objective factors such as their actual 
memory ability. Perhaps those with poorer memories use more strategies in order to 
compensate for deficient abilities. 
Self-reported Compliance: Accuracy and Prediction 
The primary goal of the present study is to evaluate self-reported compliance. 
Self-reports of compliance are used everyday by physicians and older adults alike. This 
information is part of the foundation for decisions about changes in regimens and for 
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compliance behaviours. Self-reported compliance has been described as a “domain 
specific metamemorial judgement” or “an estimate of one’s memory ability within the 
particular domain of medication taking” (Gould et ah, 1997, p.l 1). However, it may be 
possible that more accurate self-reports of compliance reflect more than metacognitive 
factors. For example, when older adults are encouraged to consider their compliance for 
each medication separately, rather than provide a global assessment that generalizes 
across all their medications, it may be found that such focused assessments are more 
accurate (driven by objective health factors) than the global assessments. 
In replication of the Gould et al. (1997) study, the present study uses a measure of 
compliance representing five important components of medication compliance (Morrow 
et al., 1991). However, in the Gould et al. (1997) investigation participants were asked 
to report their compliance with all of their medications at once while participants in the 
present study reported their compliance with each of their medications separately. 
Because focused questioning results in more accurate patient recall (Rost & Roter, 1987), 
this more specific method of questioning is expected to result in more accurate 
information regarding past compliance. 
If self-reports reflect compliance objectively using this more focused method of 
questioning, then medical or cognitive variables are expected to contribute to the 
prediction of self-reported compliance. However, if self-reported compliance is not tied 
to more objective health indicators, then subjeetive belief related variables are expected 
to predict perceived compliance as in the Gould et al. (1997) study. 
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Self-reported Compliance: A Path Model 
As described earlier, self-reported compliance is not only a metacognitive 
assessment but also a health behaviour, and despite much work with metacognitive 
models and much investigation of the role of health beliefs in predicting health 
behaviours, there are currently no metacognitive models that deal specifically with the 
health behaviour of medication compliance. The present study seeks to investigate such a 
metacognitive model in order to understand both the actual compliance task and self- 
reports of compliance. 
It is logical that the importance that older adults place on the task of compliance 
should predict their compliance, indeed this is supported by the correlation reported in the 
Gould et al. (1997) study. However, if self-reported compliance does reflect actual 
compliance (at least to some degree), it is expected that beliefs about the importance of 
compliance will drive compliance behaviours such as strategy use. In fact, Gould et al. 
(1997) reported a significant relationship between the importance of compliance and four 
types of strategy use. Further, many studies have demonstrated significantly better 
compliance when strategies were employed (Coe, Prendergast & Psalhas, 1984; Park et 
al., 1991). 
Thus the present study seeks to examine a path model whereby the importance of 
compliance predicts compliance through the use of memory strategies as described in the 
PMMQ. Further, the importance of compliance is expected to predict compliance 
differentially through retrospective versus prospective strategy use because compliance 
errors are more likely to be prospective than retrospective (Bernstein et al., 1989; Col et 
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al., 1990; Park et al.„ 1992; Swonger & Burbank, 1995) and because of the distinction 
between prospective and retrospective components of memory (Devolder & Pressley, 
1992; Einstein & McDaniels, 1996; Gould et al., 1997; Zelinski et al., 1990). 
Chapter Three: Method 
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Method 
Participants 
A total of 61 older adults recruited from local seniors’ groups and from the 
general community volunteered to participate in this study. Nine were rejected from the 
sample because they had more than two missing data points on key scales, and two were 
rejected because they required visual assistance in completing the questionnaires. 
However, 14 of the remaining 50 individuals had only one or two missing data points on 
multiple item scales and were excluded from analyses involving those data points. The 
missing data points were random as determined by the use of dummy variables 
(Tabachnick & Fidell, 1996), and in all analyses there were at least 47 cases available, 
although there were usually 49 cases available for analyses in the event of missing data. 
The remaining 50 participants ranged in age from 51 to 83 years with a mean of 
70.1 years, which is 5.8 years lower than the mean age in the Gould et al. (1997) research. 
The current research had 20 male and 30 female participants, which is very similar to the 
Gould et al. (1997) study which had 19 male and 32 female volunteers. In the present 
study, 30 participants (60%) were married, 14 (28%) were widowed, 4 (8%) were 
divorced, 1 (4%) was living common-law, and 1 (4%) was single. Seventeen (34%) of 
the older adults lived alone and 33 (66%) lived with someone else. Twenty-two percent of 
the participants had completed elementary school, 78% completed high school, and 36% 
completed at least one year of college. The Gould et al. (1997) sample had more 
participants with both high school (88%) and college (65%) education. The mean score 
obtained on the Center for Epidemiological Studies - Depression (CES-D) Scale (Radloff, 
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1977) was 11.61 (SD=6.72), only slightly higher than the mean score of 8.4 (SD=7.9) 
obtained by the Gould et al. (1997) sample. This scale is scored out of a maximum of 60 
points with higher scores indicating higher levels of depression. 
During the five years before the study, 86% of the sample had suffered from 
between one and four medical conditions (M=2.52, SD=1.54) with a range of one to six 
conditions. The participants were taking an average of 3.18 medications(SD=2.25), which 
is quite similar to the average of 3.14 medications (SD=1.98) taken by the participants in 
the Gould et al. (1997) sample. More specifically, 52% of the current study’s volunteers 
were taking 1 or 2 medications (M=1.35, SD=.49), with a range of 1 to 14 medications. 
The mean for those participants taking 3 or more medications was 5.17 (SD=2.81). 
During the 12 months before the study, 24% of the sample had seen a doctor one time, 
and 50% had seen a doctor between two and five times. This too is similar to the average 
of two to five visits in the Gould sample. Also, 82% of participants had not stayed 
overnight in the hospital in the past year. At the time of the study, 80% of participants 
rated their health as “good” or “very good” compared to a perfect state of health, a 




Compliance for each participant was measured with five questions for each 
medication being taken (see Appendix A). For example, a person taking three 
medications would answer the five questions for each medication (a total of 15 
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questions). Participants were asked to rate, on a five-point scale, how often they take 
each medication: a) exactly as prescribed, b) exactly at the time prescribed, c) exactly in 
the correct amount. Using the same scale, they were also asked to report how often they 
remember: d) the name of the medication and, e) information about side-effects and 
things to avoid while taking the medication. Previous research has shown that these five 
items are important components of medication compliance (Morrow, Leirer, Altieri & 
Tanke, 1991). For each of these questions, the participant could choose to respond with 
(1) over 90% of the time, (2) 75% to 90% of the time, (3) 50% to 75% of the time, (4) 
25% to 50% of the time, or (5) less than 25% of the time. Self-reported compliance for 
each participant was defined as the average response across the five questions for all 
medications the participant was taking. The range of possible scores for self-reported 
compliance was from 5 to 25 where a high score reflects lower perceived compliance 
with medication regimens. 
Importance of Compliance 
Participants were asked to report if it was important to them to comply with their 
medication instructions for each medication (see Appendix A). It is crucial to inquire 
about patients’ beliefs regarding the importance of compliance with their medications 
because these beliefs have been strongly correlated with compliance in past research 
(Gould et al., 1997), and because of the demonstrated importance of health beliefs in 
health behaviours (Rosenstock, 1990). For eaeh of the five components of compliance 
listed above, the participant could choose a response regarding the importance of 
compliance from a five-point likert scale: (1) agree strongly, (2) agree, (3) undecided, (4), 
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disagree, and (5) disagree strongly. As in self reported complianee, the importance of 
compliance for each participant was defined as the average response across the five 
questions for all medications the participant was taking. For example, a person taking 
three medications would answer the five questions for each medication for a total of 15 
questions. A person taking four medications would answer 20 questions in total. The 
range of possible scores for perceived importance of compliance was also 5 to 25, with a 
high score reflecting lower importance of compliance. 
Medications and Medical Factors 
Whether or not people take their medication correctly may depend, in part, on a 
number of medical factors. For example, regimen complexity (number of different pills 
per day and number of doses per medication) has often been demonstrated to contribute 
to noncompliance (Bernstein et al., 1989; Blackwell, 1973; Boczkowski & Zeichner, 
1985; Botelho & Dudrak, 1992; Col et al., 1990; Conn et al., 1991; Darnell et al., 1986; 
Graveley & Oseasohn, 1991). Further, noncompliance is assumed to be more likely when 
the medication is prophylactic rather than treatment for a current serious condition, or 
when discontinuing treatment does not result in immediate consequences such as 
discomfort (Blackwell, 1973). Certainly, older adults who report higher ratings of 
seriousness for their symptoms also demonstrate more active involvement in coping 
behaviours such as medication compliance (Cameron, Leventhal & Leventhal, 1993). 
Because of the demonstrated correlation between compliance and these four medical 
factors, the number of medications being taken by each participant, the number of 
medical conditions, and the seriousness and discomfort scores for each condition being 
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treated were standardized separately, then summed to create a single standardized medical 
variable. 
Number of medications and number of conditions. A medication questionnaire 
was administered for each medication a participant was taking at the time of the study. 
Each questionnaire requested the name of a medication and the condition being treated 
by the medication (see Appendix A). Participants were encouraged to bring a list of their 
medications to complete this portion of the study, although very few participants did. 
Subjects were also asked to record any conditions they had suffered from in the past five 
years (see Appendix P). The number of medications was summed as was the history of 
medical conditions reported. Participants were taking anywhere from 1 to 14 medications 
at the time of the study, and reported suffering from zero to six conditions in the past 5 
years. 
Seriousness and discomfort. Two pharmacists were asked to rate the seriousness 
of each illness a participant reported suffering from and the level of discomfort associated 
with noncompliance (see Appendix B). Each medication was listed with the condition it 
was treating, and this list was given to two pharmacists who were blind to the purposes of 
the study. They provided independent ratings of the seriousness of each condition being 
treated, and the discomfort that would result from the condition if the medication was not 
taken for 1 to 2 days. 
If life threatening complications would result from noncompliance, a high 
seriousness rating was given. A medium rating was given if long-term life threatening 
complications would result without treatment. Finally, a low seriousness rating was 
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given when failure to receive treatment would not necessarily lead to life threatening 
complications. Inter-rater reliability for seriousness ratings was .98. The seriousness 
scores were weighted to reflect greater importance for the medical conditions with high 
seriousness (low=l, medium=4, and high=9). The seriousness score for each participant 
was an average of the weighted seriousness scores for all self-reported medical 
conditions. For example, when two medications were being taken for two separate 
medical conditions with different serious ratings (low = 1 and high = 9), a seriousness 
score of five will have been assigned. 
If discomfort was likely to occur from not taking a medication for 1 to 2 days a 
“yes” rating was assigned; if discomfort was not likely to occur, then a “no” rating was 
assigned. Inter-rater reliability for discomfort ratings was .92. To place more importance 
on medications prescribed for greater discomfort, a weighted score of one was allotted for 
no discomfort, and a score of four was allotted for discomfort. The discomfort score for 
each participant was an average of the weighted discomfort scores for all of their reported 
medical conditions. For example, when three medications were being taken for three 
different conditions with different discomfort ratings (yes = 4, no = 1, and no = 1), a 
discomfort score of two will have been assigned. 
Cognitive Performance 
Time based prospective memory. The time based memory task required the 
participant to remember to do something at a specific time in the future, as would be the 
case when one is required to remember to take a medication at a specific time in the 
future (i.e., 4:30 p.m.). The researcher asked each participant to remind her to make an 
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important telephone call “in twenty minutes” (see Appendix C); therefore the target time 
for this task was 20 minutes from the time of the researcher’s request. A possible score 
of 0 to 3 could be earned for this task. Participants were awarded a score of “0" if they 
forgot to remind the researcher to make a call. A score of “1" was awarded if the 
participant reminded the researcher to make the call more than 10 minutes before or after 
the 20 minute target time. A score of “2" was awarded for reminding the researcher to 
make the call within 3 to 10 minutes of the target time, and a score of “3" was awarded 
for reminding the researcher to make the call within 2 minutes of the target time. A high 
score indicates better performance on the time based prospective memory task. 
Event based prospective memory. When the questionnaire package was 
introduced (Personal Information Sheet, Prospective Memory for Medications 
Questionnaire, Metamemory In Adulthood Questionnaire, and the Centre for 
Epidemiologic Studies-Depression Scale), the researcher asked the participant to remove 
any messy pages, and write the name of the questionnaire on the back of the messy sheet. 
The name of each questionnaire was clearly marked on the front of each instrument. 
Participants could have encountered the messy page from 30 minutes to one hour from 
the time the task was mentioned, depending on the individual’s pace in filling out the 
questionnaires; the page was embedded in approximately the center of the package. The 
messy page (found in Appendix D) served as an event or memory cue for this prospective 
task. A score of 0 to 3 was possible on this task. A score of “0" was awarded for doing 
or saying nothing about the messy page. One point was awarded for recognizing that 
there was something to be done with the messy sheet (e.g., questioning the researcher 
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about what was to be done with the page). One point was also awarded for removing the 
sheet, and one point was awarded for writing the name of the questionnaire on the back of 
the sheet. These points were then summed to obtain the total score for the event based 
prospective memory task (see Appendix E). A higher score indicates better performance. 
Time based and Event based prospective memory scores were simply summed to 
create a prospective memory variable which was then standardized and summed with the 
retrospective standardized variable to create a single standardized memory performance 
variable. These variables were summed to provide a subject to variable ratio suitable for 
regression analyses. 
Retrospective text recall. Participants were given a one page text containing 
information about a pseudo medication (Appendix F). The instruction format was based 
on information distributed by pharmacists about real medications and included the name 
of the medication, instructions about how to take the medication, and cautions and 
possible side effects associated with this medication. The pseudo medication, however, 
was designed so that the medication information would not reflect any real medications 
that participants might be taking. Participants were asked to read the information as if it 
was being prescribed to them by their doctor (Appendix G). Participants were 
encouraged to take as long as they needed to read the text. When finished, they were 
given a blank sheet of lined paper and were asked to recall, in their own words, as much 
of the text as possible. There were 158 propositions in the text, and one point was given 
for each proposition recalled up to a maximum score of 158. Scoring of the medication 
text propositions by two independent raters had an inter-rater reliability of .95 (tested on 
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18% of the sample). A high proposition score reflects better memory performance. 
Retrospective subject performed tasks fSPTs). Thirty-five word-pairs (Appendix 
H), consisting of a verb and a noun that together made a simple one step action, were 
presented to each participant at 10 second intervals. Previous research has indicated that 
this is an acceptable rate of presentation (McDonald-Miszczak, Hubley, & Hultsch, 
1996). Following task instructions (Appendix I), participants were informed that they 
would be required to remember the list of word-pairs after completion of the task. After 
all 35 word-pairs had been repeated verbally and each action had been performed by the 
participant, a sheet of paper was provided in order for subjects to recall as many of the 
word pairs as possible in seven minutes (Appendix J). No participants required more 
than seven minutes to complete the recall task. One mark was given for each word-pair 
or word-pair synonym recalled. The maximum score was 35. The text proposition recall 
score and the SPT score were eaeh standardized and then summed to create a 
standardized retrospective cognitive variable. 
Strategy Use and the Usefulness of Strategies - PMMQ 
The Prospective Memory for Medications Questionnaire (PMMQ) is a 28-item 
scale used to measure both the perceived use and usefulness of memory strategies for 
taking medication (Appendix K). These strategies were developed for the Gould et al. 
(1997) study, and they were based on the Metamemory In Adulthood Questionnaire 
(MIA; Dixon et al., 1988) memory strategy scales. Participants rated how often they used 
each medication strategy on a five point likert scale (1 = never to 5 = always). The 
maximum score possible is five, and a high score indicates greater strategy use. 
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Participants then rated the usefulness of each strategy on a five point likert scale (1 = 
agree strongly to 5 = disagree strongly). The maximum score is five, and a high score 
reflects lower perceived usefulness of strategies. 
For some analyses, the PMMQ was subdivided into four memory strategy scales. 
Seven questions were classified as external prospective (E-P), seven questions were 
classified as external retrospective (E-R), four questions were classified as internal 
prospective (I-P), and 10 questions were classified as internal retrospective (I-R) (Gould 
et al., 1997). 
The PMMQ was also subdivided into two memory strategy scales for path 
analyses in order to investigate whether retrospective and prospective strategy use would 
differentially predict compliance. Eleven questions were classified as prospective, and 
seventeen questions were classified as retrospective. Scores for each of the strategy 
subscales were composed of the average of a participant’s responses across all items in 
that scale. Total scores for both strategy use and strategy usefulness were also composed 
of the average of a participant’s responses across all items in that scale, and these final 
scores were standardized for use in regressions with other standardized composite scores. 
Memory Beliefs 
The Metamemory in Adulthood Questionnaire (MIA; Dixon et al., 1988) was used 
to measure beliefs about memory by asking people to agree or disagree with statements 
regarding a variety of everyday memory situations (Appendix L). Three scales were used 
in the present study: memory capacity which is a measure of participant’s beliefs about 
her own memory abilities, memory anxiety which is a measure of participant’s anxiety 
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about her memory in various situations, and memory change which is a measure of 
perceived change in her memory performance over the past ten years. The MIA has 
demonstrated good reliability on all scales with Cronbach’s alphas ranging from .81 to 
.93 (Dixon et al., 1988; Hultsch et al., 1988). The Cronbach alphas in the present study 
sample for anxiety, capacity, and change were .83, .87, and .84 respectively. Participants’ 
responses to the statements about their memory ranged from (1) agree strongly to (5) 
disagree strongly, with five being the maximum possible score. A high score for each 
scale reflects belief in high memory capacity, low anxiety about one’s memory in various 
situations, and belief in memory stability over the past ten years. Anxiety, capacity, and 
change scores were determined by using the average of a participant’s responses across 
all items in that scale. All three scales were standardized separately and then summed to 
create a single standardized composite “memory beliefs” score for use in regression 
analyses. 
Procedures 
Older adults were recruited from the general community of Thunder Bay through 
local seniors’ groups such as the Herb Carol 55+ Centre and seniors’ church groups, from 
information booths set up at local shopping malls, and from the registrar’s list of 
Lakehead University students over the age of 55. These older adults were provided with 
a short presentation explaining the main purpose of the study followed by an opportunity 
to volunteer. Potential volunteers filled out a short form (Appendix M) to indicate their 
interest in participating in the study, and these forms were used to contact the volunteers 
by telephone to set up an appointment to participate in the study, and to answer any 
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questions about what their participation would involve. Volunteers were not paid for 
their participation in the study. Acceptance criteria for participants required that the 
volunteers were over the age of 55 (except in two cases where participants were close to 
55 and fulfilled all other participation requirements), were taking at least one prescription 
medication at the time of the study, were free from apparent cognitive impairment, were 
mobile, and were able to complete the questionnaires and memory tasks independently. It 
is important to note that these older adults represent a healthy population of older adults, 
as evidenced by their involvement in activities and higher education outside of their home 
environment. Once it was determined that the acceptance criteria were met, an 
appointment was made for the volunteer to come to the university, at their convenience, 
for approximately one and one-half to two hours to complete the questionnaires and 
perform the memory tasks. Subjects were encouraged at this time to bring a list of the 
medications they were currently taking. 
Upon arrival, the participant was immediately shown to a comfortable chair at a 
large table with a pen and a digital clock. Next, the researcher explained the purpose of 
the study (Appendix N), the procedures that would be followed, and the risks and benefits 
of participation. A consent form was then presented to each participant (Appendix O). 
Next, the participant completed the medication questionnaires, and the researcher 
presented the volunteer with the remaining questionnaires to be completed. These 
included the personal information questionnaire (Appendix P), the PMMQ (Gould et al., 
1997), the MIA (Dixon et ah, 1988), and the CES-D (Appendix Q; Radloff, 1977). The 
researcher then asked the participant to remind her to make an important telephone call in 
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20 minutes. When the volunteer had agreed to do this, the researcher thanked the 
participant and introduced him or her to the questionnaire package. As an apparent 
afterthought, before the researcher left the room, she explained that there had been trouble 
with the photocopier, and that some of the copies were not clear. The participant was 
asked to tear out any messy pages she encountered, and write the name of the 
questionnaire on the back of the page. At this point, the participant was again reminded 
to call the researcher in 20 minutes. As the researcher left the room, she started a stop 
watch to record the time that elapsed from this point until the participant reminded her to 
make the telephone call. The time was recorded in minutes and seconds. 
Once the questionnaire package was complete, the questionnaires were removed 
from the table, and the participant was given the medication text. Participants were asked 
to read the text just as if they were prescribed the medication by their physician. There 
was no time limit for reading the text. When the participant indicated that she had 
finished reading the text, a blank sheet of lined paper was provided, and she was asked to 
recall as much of the text as possible, in her own words. 
After completion of this task, the participant was asked to come into a smaller 
office, and sit across from the researcher at a desk. The researcher had a screen set up 
with items hidden from the participant’s view. The participant was instructed that a recall 
task was about to take place, and that she would be required to remember a list of 35 
word-pairs that make up actions. Participants were then told that this task would involve 
three steps. First, the researcher would read a word-pair out loud at a rate of one word- 
pair every ten seconds; for example “Smell flower.” Second, the participant was to repeat 
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the word-pair out loud. Third, the participant was to perform the action quickly and 
efficiently (any necessary items were provided, a flower in this example). After all 35 
word-pair tasks had been performed, the participant was given a sheet of paper and seven 
minutes to recall as many of the word pairs as possible. 
Once this task had been completed, the researcher debriefed the participant 
(Appendix R). The cover stories for the time-based (phone call) and event-based (messy 
page) prospective tasks were described, and the researcher explained that these tasks were 
planned portions of the experiment. The researcher explained that she had asked the 
participant to perform these memory tasks to get an accurate measure of certain types of 
memory, and that the purpose of the memory tasks in this study was to understand the 
relation between self-reported compliance rates and memory ability. 
Chapter Four: Results 
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Results 
Analyses were performed to describe older adults’ use of strategies for medication 
compliance, and to predict strategy use from a range of variables including medical 
factors, memory performance, importance of compliance, and memory beliefs. 
Secondly, analyses were performed to predict self-reported compliance from a range of 
variables including medical factors, cognitive performance, strategy use, perceived 
importance of strategy use, and memory beliefs. Finally, path analyses were performed to 
investigate whether the importance of compliance predicts self-reported compliance 
through strategy use. 
Mean-Level Analyses 
In preliminary analyses, mean level performance scores on all of the variables 
included in regression analyses were examined (see table 1). These included self- 
reported compliance, perceived importance of compliance, medication and medical 
factors, cognitive performance, strategy use, the perceived usefulness of strategies, and 
memory beliefs. 
Older adults in this sample reported that they complied to their medications over 
90% of the time, and although they reported that they agreed it was important to comply 
to their medications, they did not strongly agree. At the time of the study, older adults 
were taking an average of three medications (see table 2), and 86% reported suffering 
from one to four medical conditions in the past five years. These figures are consistent 
with other studies examining medication use in older adult populations, and with the 
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Table 2. 
Sample description of compliance, the importance of compliance and medical 
factors. 





Importance of Compliance 
Number of medications at the time of study: 
Total sample 
52% of sample 
48% of sample 
Number of conditions suffered in past 5 
years: 
Seriousness of the medical conditions 





















Consistent with past research, older adults performed better on the SPT word- pair 
task than they did on the text recall memory task (Kausler, 1989). Unlike past research 
however (Einstein et ah, 1995; Einstein et ah, 1990; Maylor, 1990; Moscovitch, 1982), 
older adults performed better on time based than event based prospective memory tasks 
(see table 3). Table 3 also demonstrates that the older adults in this sample held relatively 
positive beliefs about their memory. Finally, older adults in this sample were more likely 
to agree that a strategy would be useful than they were to report actually using that 
strategy regularly (see table 4). 
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Table 3. 
Sample description of metamemory and memory performance. 




Prospective Memory Performance: 
Event based 
Time based 
Retrospective Memory Performance: 
SPT Word Pairs 
Text Recall Propositions 
Memory Beliefs: 
Anxiety (hi score=low anxiety) 
Capacity (hi score=hi capacity) 





















Older Adults Use of Medication Memory Strategies 
The first goal of the present study, in replieation of the Gould et al. (1997) study, 
was two-fold: to examine older adults’ reports of their use of internal and external 
memory strategies for medication compliance and to predict strategy use from a range of 
variables. Older adults were expected to report using internal memory strategies more 
often than external memory strategies for medication compliance (Gould et al., 1997). 
Two possible outcomes were proposed for the prediction of strategy use in the 
current sample. The first possible predicted outcome was a replication of the Gould et 
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Table 4. 
Sample description of strategy use and the perceived usefulness of strategies. 
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al. (1997) study in which two belief variables, the importanee of eomplianee and memory 
beliefs, predict strategy use. Because of the addition of actual memory performance to 
the set of predictor variables in the present study, the second possible scenario was the 
prediction of strategy use by the importance of compliance and by actual memory 
performance. 
Each of the four scales of the PMMQ were examined, and all strategies that were 
reported to be used regularly (always or often) by over 50% of the sample were identified. 
In the present study, and as found in the Gould et al. (1997) study, older adults reported 
using internal more often than external memory strategies for medication compliance, 
t(48)= -18.73, p<.001. Eight memory strategies were used regularly by over 50% of 
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older adults in this sample, and seven of these were internal strategies (see figure 1). 
Interestingly, seven of these eight strategies were also among those regularly used in the 
Gould et al. (1997) sample. 
Prediction of Strategy Use: Hierarchical Regression 
Part two of the first goal of the present study was to predict strategy use from a 
range of variables. Two possible outcomes were proposed, and the first possible outcome 
was a replication of the Gould et al. (1997) study in which two belief variables, the 
importance of compliance and memory beliefs, predict strategy use. The second 
possible scenario was the prediction of strategy use by the importance of compliance and 
by actual memory performance. This was tested using hierarchical multiple regression 
analyses for each strategy scale. 
Four regressions were performed, and the criterion variable used for each of these 
regressions was an average score for strategy use from the four (PMMQ) strategy scales: 
(1) External Prospective (E-P), (2) External Retrospective (E-R), (3) Internal Prospective 
(I-P), and (4) Internal Retrospective (TR). In each regression there were four blocks of 
predictor variables, with one variable in each block. The first block consisted of medical 
and medication factors. The number of current medications, number of conditions 
suffered over the past five years, seriousness of present conditions, and discomfort of 
present conditions were standardized separately and then summed to create a single 
composite variable. The second block contained cognitive performance scores, a 
summary variable consisting of standardized scores for time and event based prospective 
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block was simply the average rating of the importance of self reported compliance across 
medications. The fourth block contained a summed memory belief variable made up 
from standardized memory anxiety, memory capacity, and memory change scores. 
Neither memory performance nor memory beliefs predicted any of the strategies 
significantly. However, the importance of compliance significantly predicted the use of 
certain strategies. Table 5 contains the results for the prediction of internal strategies. 
None of the variables significantly predicted the use of internal strategies. However, 
although not significant, the importance that older adults placed on compliance predicted 
the use of I-P but not I-R strategies at p=.056. Table 6 contains the results for the 
prediction of external strategies. The importance that older adults placed on compliance 
significantly predicted the use of E-P but not E-R strategies at p=.01. 
Prediction of Self-reported Compliance: Hierarchical Regression 
The second goal of the present research was to investigate self-reported 
compliance. If self-reported compliance is tied to objective factors due to the more 
specific questions being asked, then medical and cognitive variables were expected to 
play a greater role in perceived compliance. However, if self reported compliance is not 
tied to more objective factors, belief related variables were expected to play a greater role 
in perceived compliance as they did in the Gould et al. (1997) study. 
Hierarchical multiple regression was used to determine predictors of self-reported 
compliance. The criterion variable was the average rating of compliance across 
medications, and the predictor variables were entered in four blocks. The first block 
consisted of medical and medication factors. The number of current medications, 
Table 5 
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Predictors of older adults' use of internal medication strategies 
Block Variables B change change 
DV = INTERNAL PROSPECTIVE (!-P) STRATEGIES (Total RSQ = .17) 
1. Medical Factors .22 .05 1.95 
2. Cognitive Performance -.03 .00 .04 
3. Importance of Compliance -.33* .10 3.90* 
4. Memory Beliefs -.16 .02 .98 
DV = INTERNAL RETROSPECTIVE (l-R) STRATEGIES (Total RSQ^.IO) 
1. Medical Factors .11 .01 .47 
2. Cognitive Performance -.06 .00 .12 
3. Importance of Compliance -.27 .07 2.59 
4. Memory Beliefs -.15 .02 .84 
p = .056 
number of conditions suffered over the past five years, seriousness of present conditions, 
and discomfort of present conditions were standardized separately and then summed to 
create a single composite variable. The second block contained cognitive performance 
scores, a summary variable consisting of standardized scores for time and event based 
prospective task performance as well as standardized text recall and task recall scores. 
Block three contained two variables: the average rating of strategy use for medication 
compliance, and the average rating of the importance of strategy use for medication 
compliance. Both variables in block three were standardized. The fourth block contained 
the same memory belief variable described in the analyses above. As 
Table 6 
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Predictors of older adults' use of external medication strategies 
Block Variables B R' change change 
DV = EXTERNAL PROSPECTIVE (E-P) STRATEGIES (Total RSQ = .17) 
1. Medical Factors .05 .00 .10 
2. Cognitive Performance -.08 .01 .25 
3. Importance of Compliance -.42* .16 6.81* 
4. Memory Beliefs -.07 .00 .18 
DV = EXTERNAL RETROSPECTIVE (E-R) STRATEGIES (Total RSQ=.05) 
1. Medical Factors .11 .01 .44 
2. Cognitive Performance -.16 .02 .88 
3. Importance of Compliance .02 .00 .02 
4. Memory Beliefs -.13 .02 .60 
p=.01 
hypothesized if self-reported compliance was tied to more objective factors due to more 
specific questions being asked, medical factors contributed significantly to the prediction 
of self-reported compliance (see table 7). 
Prediction of Self-Reported Compliance: A Path Model 
The third goal of the present research was to investigate a model of compliance 
using the new, possibly more objective, measure of self-reported compliance. It was 
hypothesized that the importance of compliance would predict self-reported compliance 
differentially through prospective and retrospective memory strategy use. 
This was tested using a set of multiple regressions followed by a path analyses. 
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Table 7 
Predictors of older adults^ self-reported compliance (Total R$Q = .20) 
DV = SELF REPORTED COMPLIANCE 
Block Variables B change F 
1. Medical Factors -.31 .10 4.00* 
2. Cognitive Performance -.08 .01 .24 
3. Strategy Use .22 
Strategy Usefulness .13 .05 1.11 
4. Memory Beliefs .22 .04 1.88 
* p=.05 
The first regression contained strategy use (either prospective or retrospective) as the 
criterion variable, and the importance of compliance as the predictor variable. 
Compliance was the criterion variable for the second regression, and both the importance 
of compliance and strategy use (either prospective or retrospective) were entered in a 
single block as the predictor variables. The importance of compliance predicted 
compliance significantly through prospective but not retrospective strategy use (see 
Figure 2). 
The hypothesized mediation of the relationship between the importance of 
compliance and self-reported compliance by the use of strategies was tested using 
LISREL 7. Path analyses were performed on the correlation matrix for four measured 
variables with one independent variable (IV), and three dependent variables (DV). The 
IV was the importance of compliance, and the DV’s were compliance, retrospective 
strategy use, and prospective strategy use. The linkage from retrospective strategy use to 
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compliance was fixed at zero based on the preceding multiple regression analyses. There 
was no significant difference between the prediction of the model and the sample data, x“ 
(1) = .00, p = .958. Further, the fit of the model was nearly perfect with 1 degree of 
freedom, both the goodness of fit index and the adjusted goodness of fit index were = 
1.00. There were significant links from the importance of compliance to prospective 
strategy use, retrospective strategy use, and to compliance, and from prospective strategy 
use to compliance. There was no link from retrospective strategy use to compliance. As 
with the multiple regressions, the importance of compliance predicted compliance 
significantly through prospective but not retrospective strategy use (see figure 3). 
The model accounted for approximately one- third (r^ = .341) of the total 
variance, and the maximum likelihood ratios indicated significant amounts of unknown 
variance for the three DV’s: retrospective strategy use (6 = .927), prospective strategy use 
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Discussion 
Mean Level Analyses 
Although this sample of older adult volunteers is fairly representative of most 
samples of older adults who volunteer to participate in similar studies (e.g., Gould et ah, 
1997), it must be recognized that this sample is a sample of convenience, and is not 
representative of the general older adult population. Participants were relatively healthy, 
free of apparent cognitive impairment, mobile, white, middle class adults with a relatively 
high level of education. Further, these people volunteered their time to participate in this 
study, and this fact alone sets them apart from those adults who chose not to volunteer 
their time. Those who volunteered may have an interest in memory and medication 
taking that motivates them to be more likely to adhere to medication regimens than the 
general population. Those who were isolated in their homes were not invited to 
participate merely because they were not actively participating in local seniors’ groups, 
and therefore were not accessible. The older adults in this study represent an active, 
highly functioning segment of the older adult population. 
Older Adults’ Use of Medication Memory Strategies 
The present study had three goals. The first goal was to conduct an investigation 
of older adults’ use of memory strategies in real life in order to replicate Gould et al.’s 
(1997) research. As in the Gould et al. (1997) study, internal memory strategies were in 
fact used more frequently than external strategies for medication compliance. Older 
adults reported the regular use of eight memory strategies, and seven of these were 
internal rather than external memory strategies. 
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Further, seven of these eight strategies (including the single external strategy) 
were also among those strategies regularly used by the sample of older adults in the 
Gould et al. (1997) study. The strategies that were used regularly by both samples were: 
leaving pills in a prominent place (E-P), concentrating on verbal instructions (I-R), trying 
hard to learn new amounts (I-R), concentrating to learn times (I-R), reading instructions 
slowly (I-R), relating times to routines (TP), and planning medication schedules in the 
morning (TP). 
The use of strategies commonly reported by older adults in both of these studies 
demonstrates an important finding about what types of strategies are being used by older 
adults to remember their medications. Older adults choose to use internal memory 
strategies rather than external strategies to remember their medications. It is interesting 
that older adults chose internal strategies over external strategies for medications yet they 
were more likely to use external strategies for everyday memory (Gould et al., 1997; 
Loewen, Shaw, & Craik, 1990). 
In the Gould et al. (1997) study, anxiety predicted the use of internal strategies for 
medication memory, and low memory self efficacy predicted the use of external strategies 
for medication memory. Post Hoc analyses revealed that anxiety predicted the use of 
internal medication strategies in this sample as well (p<.05). However, low memory self 
efficacy did not predict the use of external medication memory strategies, but it did 
predict the use of everyday external memory strategies (p=.06). The pattern holds true in 
that anxiety in both studies was related to the use of internal strategies, and low memory 
self-efficacy was related to the use of external strategies. 
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Perhaps anxiety leads to worry and rumination about medication regimens, thus 
increasing the internal rehearsal of memory instructions. It is reasonable however, that 
low memory self-efficacy may lead an older adult to choose external strategies. It would 
make sense that an older adult with low levels of memory self-efficacy would choose not 
to use internal strategies for memory, because these strategies almost seem to imply 
reliance on one’s own memory. External strategies, however, may be the strategy of 
choice because they serve as reminders outside of one’s own mind or memory. 
Reasons other than memory anxiety may also contribute to the choice of internal 
strategies in older adults for medication compliance. Perhaps older adults choose internal 
strategies because they are portable and invisible strategies. It is possible that in our 
society youthful qualities are overvalued, and the use of external (and therefore 
noticeable) memory aids are considered a erutch or a weakness, a sign of “old age” and 
failing memory. Older adults may be influenced by such attitudes to choose to use less 
conspicuous (internal) memory strategies for their medication compliance. 
Perhaps anxiety about memory performance is affected by such attitudes and 
beliefs, and it is through anxiety that these beliefs predict the use of internal strategies for 
medication compliance. Recall that low memory self efficacy predicted the use of 
external medication strategies in the Gould et al. (1997) sample, and was correlated with 
the use of external everyday memory aids in the present sample. What is not clear from 
either of these studies is wether low memory self efficacy is caused by poor memory 
performance, or wether it is related to the attitudes held by older adults about their place 
or value in society. It is possible that such attitudes drive the choice to use memory 
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strategies, whether internal or external. 
Not only do older adults choose to use internal strategies for medication 
compliance, but five of the eight regularly used strategies were retrospective rather than 
prospective. Perhaps older adults’ perception of “poor memory” does not include 
prospective memory, but is built on the concept of memory for recent events, or recall of 
learned information rather than on performing some task in the future. Based on this 
definition of memory performance, retrospective strategies would seem a natural choice 
for guarding against memory failure in medication compliance. 
It is also possible that the emphasis in the physician’s office is on retrospective 
components of compliance, such as dose and side effects, rather than on the prospective 
issue of when to take the medication. In fact, post hoc analyses in the present sample 
revealed that older adults placed significantly more importance on retrospective 
components of compliance (how much medication do I take?) than on prospective 
components of compliance (when do I take my medication?), / (48) = -2.08, p < .05. It 
may be that the prospective task is considered “obvious” by prescribing physicians and 
pharmacists, and is overlooked as a result. 
Indeed, medications are often to be taken “twice daily” or “four times daily” and 
no further instructions are provided for the prospective component of the task. For 
example, “With meals” may be a problematic instruction for those who do not eat three 
meals per day if the intention is to take the medication three times daily. It may make 
more sense for physicians to spend a few more minutes initially to get to know the routine 
and the preferred memory strategies of the patient so that the prospective task can be 
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prescribed specifically to fit into their patient’s daily routine. 
It is also possible that the measurement instrument is biased towards retrospective 
strategy endorsement. There are 28 strategy use items in total, with equal numbers of 
internal and external items (14 each), but with 11 prospective and 17 retrospective items. 
Perhaps there is a higher probability of endorsing more retrospective items. It may be 
that creating an equal number of items for each of the four strategy use categories (I-P, I- 
R, E-P, and E-R) would yield different results. This is an issue for further research using 
the PMMQ. 
It is fascinating to note that most of the regularly used strategies are retrospective 
strategies, yet errors of omission (or prospective errors) are the most common type of 
medication compliance errors. It is possible that omission errors are more common 
because of such strategy use patterns in older adults, or it is possible that older adults are 
not aware of the fact that omission errors are more likely, and they focus their memory 
strategies on the retrospective components of compliance. In either case, it is important 
to note that older adults are using retrospective strategies, when the problem with 
compliance appears to be prospective in nature. 
Prediction of Strategy Use: Hierarchical Regression 
It is interesting, despite the regular use of retrospective strategies, that when 
compliance was deemed more important by older adults, they chose not to use 
retrospective but prospective strategies, as demonstrated by the significant correlation 
between the importance of compliance and the use of prospective memory strategies (p < 
.01). Only three out of eight regularly used strategies were prospective, yet these were the 
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strategies of choice when more emphasis was placed on the importance of compliance. 
When addressing compliance issues with older adults, it is clear that more 
importance needs to be placed on compliance, perhaps especially on the prospective 
components of compliance. This may increase the use of external prospective strategy 
use, and decrease the amount of medication omission errors. External prospective 
strategies have been demonstrated to be effective memory aids for compliance, and 
emphasis on the importance of compliance coupled with the careful choice of appropriate 
external prospective aids may prove to be a simple yet effective means of lowering rates 
of noncompliance in older adults. 
Prediction of Self-reported Compliance: Hierarchical Regression 
This sample, consistent with past studies, demonstrated high levels of self- 
reported compliance. However, in contrast to the Gould et al. (1997) study, objective 
medical factors, rather than subjective factors (such as metamemorial beliefs) 
significantly predicted self-reported compliance. It was hypothesized that if self-reported 
compliance was more accurate due to asking more specific questions regarding 
compliance, then objective medical or cognitive factors would predict self-reported 
compliance; and it did. 
This result however, needs to be interpreted with caution. This caution is because 
only objective medical variables and not objective cognitive variables contributed 
significantly to the prediction of self-reported compliance, and also because the subjects’ 
perceived health was not taken into account in this analyses. Perceived health may play 
an important role in older adults’ medication compliance as people may be more likely to 
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comply to medication instructions when they perceive themselves to be in poor health. 
Only one question was used to measure perceived health in this study. The participant 
was asked to rate their own health, compared to a perfect state of health, as “very good”, 
“good”, “fair”, “poor”, or “very poor”. This measure of perceived health was 
significantly correlated with self-reported compliance (as was the objective composite 
medical score used in the regression analysis), but a single question could not be used as a 
predictor variable for analyses. In future studies, if measured properly, perceived health 
may prove to be an important predictor of medication compliance. 
The memory measures in this sample need to be considered more closely as well. 
Time based prospective tasks are believed to be more difficult because of self-initiated 
retrieval, and older adults generally perform better on event based prospective tasks than 
on time based tasks. The older adults in this sample, however, performed significantly 
better on the time based than on the event based prospective memory task, t (46) = -4.50, 
/? < .001. In this sample, 23% of the older adults completely forgot to perform the time 
based prospective task, while 42% forgot to perform the event based prospective task. 
The reason for this unexpected finding may be the nature of the prospective tasks 
that were presented. Older adults were asked to remind the student researcher to “make 
an important telephone call” because she “forgot her watch” that day. This task sounded 
very important and fairly immediate, as the reminder was due in twenty minutes. The 
event based task, however, may not have held the same importance. Participants were to 
tear out any “messy pages” and write the name of the questionnaire on the back because 
of “trouble with the photocopier.” There was no indication of when this task would 
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occur, but the messy page was to serve as a cue. This task was not overtly called 
“important” as was the time based task, and the nature of the consequences of not 
performing the event based task were less serious than the phone call task. The important 
phone call could have been about anything, but it was definitely important. However, if 
they failed to notice a messy page, the worst that would happen is that someone else may 
also encounter a messy page. Perhaps the importance of the prospective task influenced 
the task performance, and changed the nature of the memory variable used in analyses. 
Further, both of these tasks were presented within a relatively short period of time, 
along with the presentation of questionnaires and instructions regarding their 
participation. There were a lot of different things to be remembered, and the older adults 
may have been most concerned with their participation, and their second concern may 
have been for the phone call because of the social nature of the task. The event based 
task may have been lowest on their list of importance, and therefore the most likely to be 
forgotten. Some older adults didn’t even remember hearing the instructions for the event 
based task when they were debriefed. Again, the perceived importance of a memory task, 
including medication compliance, may have an impact on the actual performance of that 
task. 
Older adult’s performance on the retrospective memory tasks were consistent with 
past research. Older adults performed better on the everyday actions SPT memory task 
than they did on the medication text, t{4S) = 15.39, p < .001. 
Prediction of Self-reported Compliance: A Path Model 
The importance of compliance predicted self-reported compliance through 
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prospective but not retrospective strategy use. Also, although the correlations between 
both types of strategy use to compliance and the importance of compliance were not 
significant in the regression analyses (except for one correlation), there was a pattern to 
the relationships. There was a negative relationship between the importance of 
compliance and both prospective (p < .01) and retrospective strategy use, and a positive 
relationship between self-reported compliance and both types of strategy use. This 
indicates that when older adults place a high level of importance on compliance, they are 
more likely to use memory strategies, however this relationship was significant only with 
the use of prospective memory strategies as demonstrated in the path model. However, 
when the older adults in the present study used strategies, self-reported compliance was 
lower, though this was significant only with prospective strategy use. This information 
goes counter to past research and the expectations of the present study that the use of 
strategies can improve medication compliance. 
Recall that compliance is a self-report, and reflects a domain specific 
metamemorial judgement rather than actual compliance. It is possible that the older 
adults who believe their compliance to be low (i.e., believe their memory to be poor in the 
area of medication taking) use memory strategies in order to improve their compliance. It 
would also make sense that those older adults who believe themselves to be quite 
compliant (i.e., high memory beliefs) don’t use memory strategies because they feel that 
they are doing fine without them. It is also possible that older adults who reported lower 
compliance were motivated to report the use of strategies in order to appear more 
compliant. It is important to note that most of the participants in this study reported a 
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high level of compliance, so there is a very restricted range of variability in compliance 
scores, and therefore Type 2 errors are likely - we may not have found what is really 
there. 
A larger sample may provide a larger range of variability, however, given the 
tendency for people to overestimate their compliance, and given the complexity of 
compliance, a larger sample may not provide the answer. The path model presented in 
this study accounted for about one-third of the total variance, which leaves two-thirds of 
the total variance unexplained. It is not surprising that this simple model does not fully 
explain the origin of self-reported compliance; this model represents only a small step on 
the path towards a full analysis of medication compliance. Self-reported compliance is a 
complex, multifaceted variable, therefore many unknown sources of variability (i.e., 
perceived health, medical factors, beliefs about memory, memory ability, etc.) should be 
expected with a simple model that only accounts for a small number of these potential 
variances. 
This study needs to be replicated before confidence can be placed in the results of 
either the prediction of self-reported compliance from objective medical factors, or the 
mediation of the relationship between compliance and the importance of compliance by 
prospective memory strategies. Before pursuing replication however, some 
methodological changes would be in order. A metamedical factor may be an important 
next step. Requiring the subject’s ratings of perceived seriousness and discomfort to 
compare with pharmacist ratings would be an interesting study on its own, and using this 
information as a perceived health scale would allow a more balanced comparison 
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between objective and subjective factors. The prediction of self-reported compliance 
could be tested using four blocks of predictors: medical factors, metamedical factors, 
memory performance, and metamemory. If more specific questions lead to more 
accurate self-reports of compliance, then objective medical or memory factors would 
predict compliance where more specific questions were used, and subjective metamedical 
and metamemorial factors would predict compliance where general questions were used. 
Measuring actual compliance as well as self-reported compliance as an additional 
dependent variable could be used to determine whether accuracy of self-reported 
compliance was being measured rather than some other unknown variable. Further, 
measuring actual compliance along with self-reported compliance would help uncover if 
indeed more focused questioning results in more “accurate” reports of compliance, while 
allowing the metacognitive path model to be tested against more objective measures of 
compliance. The importance of compliance (a metamemorial belief) has been 
demonstrated to influence the use of strategies, and the use of strategies has been 
demonstrated to influence self-reported compliance, though not as expected. It is likely 
that, controlling for differences in memory ability and other sources of variance, the use 
of memory strategies does indeed have a positive impact on compliance, and this may be 
tested using more objective measures of compliance than a focused self-report. 
The next step in the study of memory for medication compliance would require a 
number of changes to the present study. The researcher would need to test the accuracy 
of more specific questions for self-reported compliance as outlined above, and to design 
prospective memory tasks with equal importance. Also, the PMMQ questions could be 
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balanced in order to match the number of items measuring prospective and retrospective 
memory strategies. A memory belief scale specific to medication compliance could be 
developed to examine the effect of everyday memory anxiety vs. medication compliance 
memory anxiety on the choice of strategy, and to measure the attitudes and beliefs that 
older adults have about memory (internal vs. external, retrospective vs. prospective). 
This would test whether or not memory beliefs predict strategy use through anxiety and 
low memory self-efficacy. In future studies, after replication of this simplistic model, 
path analyses could be used with a larger sample to test a more complex model, or to test 
competing metacognitive models of compliance in order to better understand the complex 
task of medication compliance. 
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APPENDIX A 
ID:  MED:  
Please provide the following information for medications you 
have taken IN THE LAST MONTH. 
MEDICATION 
a) Name of the medication:  
b) Condition treated by this medication:  
c) WHEN you are supposed to take this medication: 
d) HOW MUCH of this medication you are supposed to take 
each time: 
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ID:  MED:  
1. Please indicate which physical symptoms you have 
experienced due to your prescribed medication during 
the last month. 




d. Chest pain 
e. Difficulty breathing or shortness of breath 
f. Pain in muscles or joints 
g. Numbness or tingling in parts of your body 
h. Indigestion, heartburn or gas 
i. Constipation 
j. Diarrhea 
k. Heart pounding, fluttering or racing 
l. Shaking or trembling 
m. Swollen ankles 
n. Rashes or bruises 
o. Other, please specify: 
2. Please indicate which non-physical symptoms you have 
experienced due to your prescribed medication during 
the last month. (Please circle all that apply). 
a. Depression 
b. Increased alertness 
c. Excitement 
d. Anxiousness or nervousness 
e. Drowsiness 
f. Difficulty thinking clearly (such as trouble 
making decisions) 
g. Confusion or disorientation (such as not 
knowing what you are doing or where you are). 
h. Other, please specify: 
3. In the last month, it has been important to me to take 
my medication EXACTLY the way my doctor prescribed (at 
the right time, in the right amount, and avoiding any 
foods or beverages as recommended): 




e. Disagree strongly 
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ID:  MED:  
4. In the last month, what proportion of the time do you 
believe you have taken your medication EXACTLY the way 
your doctor prescribed? 
a. Over 90% of the time 
b. 75% to 90% of the time 
c. 50% to 75% of the time 
d. 25% to 50% of the time 
e. Less than 25% of the time 
5. In the last month, it has been important to me to take 
my medication EXACTLY at the TIME my doctor prescribed: 




e. Disagree strongly 
6. In the last month, what proportion of the time do you 
believe you have taken your medication EXACTLY at the 
TIME your doctor prescribed: 
a. Over 90% of the time 
b. 75% to 90% of the time 
c. 50% to 75% of the time 
d. 25% to 50% of the time 
e. Less than 25% of the time 
7. In the last month, it has been important to me to take 
my medication in EXACTLY the correct AMOUNTS that my 
doctor prescribed: 




e. Disagree strongly 
8. In the last month, what proportion of the time do you 
believe you have taken your medication in EXACTLY the 
correct AMOUNTS your doctor prescribed: 
a. Over 90% of the time 
b. 75% to 90% of the time 
c. 50% to 75% of the time 
d. 25% to 50% of the time 
e. Less than 25% of the time 
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ID: MED: 
9. In the last month, it has been important to me to 
remember the NAME of my prescribed medication: 




e. Disagree strongly 
10. In the last month, what proportion of the time do you 
believe you have remembered the NAME of your prescribed 
medication: 
a. Over 90% of the time 
b. 75% to 90% of the time 
c. 50% to 75% of the time 
d. 25% to 50% of the time 
e. Less than 25% of the time 
11. In the last month, it has been important to me to 
remember information about possible SIDE-EFFECTS and 
things to AVOID while taking the medication: 




e. Disagree strongly 
12. In the last month, what proportion of the time do you 
believe you have remembered information about possible 
SIDE-EFFECTS and things to AVOID while taking the 
medication: 
a. Over 90% of the time 
b. 75% to 90% of the time 
c. 50% to 75% of the time 
d. 25% to 50% of the time 
e. Less than 25% of the time 
13. In the last month, which of the following has been MOST 
difficult to remember? (Please circle only ONE 
selection). 
a. The times to take the prescribed medication 
b. The amount of medication to take 
c. The name of the medication 
d. Information about possible side-effects and 
foods and beverages to avoid while taking the medication. 
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APPENDIX B 
The following list of medications was compiled from community- 
dwelling older adults in Thunder Bay who are participating in a psychology 
study at Lakehead University. The medication names have been written 
exactly as they appeared in the study, by the participants. In addition, the 
medical conditions treated by these medications have also been written as 
they appeared in the study. In a few instances, participants were unclear on 
what condition their medications had been treating, or what the name of the 
medication was for their condition, and we have indicated this uncertainty 
by the statement “unknown”. 
We are interested in examining both the seriousness of the condition 
treated by these medications, and the discomfort which may result from not 
taking the medication prescribed for the condition. It is essential for health- 
care professionals to rate these two aspects of medication-taking 
(seriousness & discomfort), so that our analysis of these aspects will be 
valid. 
It is important that the health-care professionals DO NOT 
COMMUNICATE about their answers so that the ratings are independent. 
The researcher will return to pick up the completed forms two days after the 
forms are dropped off. Within the following two days, after picking up the 
completed forms, a researcher will contact the health-care professionals. At 
this time, it is possible that the researcher will ask the health-care 
professionals to sit down together to go over some of the items and 
collaborate on some of the answers. Again, it is important that the 
researchers DO NOT collaborate before this time. 
Each researcher will be paid $75 for their services. The cheques will 
take approximately 2 weeks to be processed following the completion of the 





(where you can be reached by the researcher within 
two days after completion of the forms) 
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INSTRUCTIONS 
SERIOUSNESS of the condition being treated 
Please place a check mark in one of the three assigned categories. 
HIGH  This rating is given if life threatening complications 
would result from not taking the medication for 1 to 2 
days. 
MED  This rating is given if long-term life threatening 
complications would result if no treatment were 
given. 
LOW  This rating is given when a failure to receive 
treatment would not necessarily lead to life 
threatening complications. 
DISCOMFORT resulting from the condition if the medication 
were not taken for 1 to 2 days. 
Please place a check mark in one of the two assigned categories. 
YES If discomfort would result from the condition, if 
medication were not taken for 1 to 2 days. 
NO  If no discomfort would result from the condition, if the 
medication were not taken for 1 to 2 days. 
* Rating scales will appear after each of the listed medications and 
medical conditions treated. 
**Please do not consult with the other professional during the ratings, 
as they are to be independent assessments. 
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ACCUPRIL 
for: high blood pressure 
Seriousness: HIGH 








Discomfort: YES  
ADVIL 
for: knee pain 
Seriousness: HIGH 
Discomfort: YES  
ALDACLAZIDE 
for: high blood pressure 
Seriousness: HIGH 
Discomfort: YES  
ALAPRIL 
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ALLQPURINQL 
for: gout 
Seriousness; HIGH  MED 
Discomfort: YES  NO  
ALPHAZOLAM 
for: insomnia 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
ALPHAZOLAM 
for: being upset 
Seriousness: HIGH  MED 






for: chest pain 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
AMQXCILLIN 
for: foot infection 
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APO ATENOLOL 
for: arrhythmia 
Seriousness: HIGH  
Discomfort: YES  
APO ATENOLOL 
for: high blood pressure 
Seriousness: HIGH  
Discomfort: YES  
APO DICLO 
for: arthritis 
Seriousness: HIGH  
Discomfort: YES  
APO-FERROUS GLUCONATE 
for: cardiovascular disease 
Seriousness: HIGH  
Discomfort: YES  
APO-FUROSEMIDE 
for: blood pressure 
Seriousness: HIGH  
Discomfort: YES  
APO-FUROSEMIDE 
for: fluid retention 
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APO-HYDRQCHLQRTHIZIDE 
for; bloating 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
APO-HYDROCHLORTHIZIDE 
for: heart 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
APQ-METRQPROLOL 
for: high blood pressure 
Seriousness: HIGH  MED 
Discomfort: YES NO 
APO-NADAL 
for: high blood pressure 
Seriousness: HIGH  MED 
Discomfort: YES NO 
APO SURFATRIM 
for: bladder infection 
Seriousness: HIGH 
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APQ TRIAMZIDE 
for: high blood pressure 
Seriousness: HIGH 
Discomfort: YES  
APQ RAMITIDINE 
for: peptic ulcers 
Seriousness: HIGH 
Discomfort: YES  
ASPIRIN 
for: blood thinner 
Seriousness: HIGH 








Discomfort: YES  
ATIVAN 
for: being upset 
Seriousness: HIGH 
Discomfort: YES 
MED  LOW 
NO 




MED  LOW 
NO 
MED  LOW 
NO 
MED  LOW 
NO 
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ATTENOLOL 
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BACTROBAN 2% 
for: nose blockage 
Seriousness: HIGH  MED 
Diseomfort; YES NO 
BETAPIC 




for: bronchial asthma 
Seriousness: HIGH  MED 
Discomfort: YES NO 
HIGH  MED 
YES NO 
BECLOSORTE 
for: lung problems 
Seriousness: HIGH  MED 
Discomfort: YES NO 
BEGAN 
for: glaucoma 
Seriousness: HIGH  MED 
Discomfort: YES NO 
BELCOMETHSAQNE 
for: sinuses 













Discomfort: YES  
CALCIUM 500 
for: lactose intolerance 
Seriousness: HIGH 
Discomfort: YES  
CAPTQPRIL 
for: high blood pressure 
Seriousness: HIGH 








Discomfort: YES  
CEPHALEXIN 
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rCIPROUNTIBIOTIC 
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CONJUGATED ESTROGENS 
for: hormones 
Seriousness: HIGH  
Discomfort: YES  
COUMADIN 
for: blood thinner 
Seriousness: HIGH  

















MED  LOW 
NO 




MED  LOW 
NO 
MED  LOW 
NO 
MED  LOW 
NO 




Discomfort: YES  
DIGOXIN 
for: low blood pressure 
Seriousness: HIGH 
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ENTREFIN 15 
for: blood circulation 
Seriousness: HIGH 
Discomfort: YES  
ENTREFIN 15 
for; still’s disease 
Seriousness: HIGH 




Discomfort: YES  
ENTROPHEN 
for: blood thinner 
Seriousness: HIGH 
Discomfort: YES  
ENTROPHEN 
for: arthritic pain 
Seriousness: HIGH 
Diseomfort: YES  
ESTRADERM 
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ESTROGEN VAGINAL CREAM 


















Discomfort: YES  
FLAGYL (METRONIDAZOLE) 

















































Seriousness: HIGH  MED 
Discomfort: YES NO 
FURSEMIDE 
for: high blood pressure 
Seriousness: HIGH  MED 
Discomfort: YES NO 
FQSAMAX 
for: Paget’s Disease 
Seriousness: HIGH  MED 
Discomfort: YES NO 
FQRMULEX 
for: diverticulosis 
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GLIBERCLAMIDE 
for; diabetes 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
GLYBURIDE 
for: diabetes 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
GEN-ATENOLOL 
for: high blood pressure 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
GEN-VERAPAMIL 
for: blood pressure 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
HUMULIN NPH 
for: diabetes 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
HYDROCHORLTHIAZIDE 
for: high blood pressure 
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HYDROCHLORIQTHIC 
for: high blood pressure 
Seriousness: HIGH 










for: high blood pressure 
Seriousness: HIGH 
Discomfort: YES  
INDOPAMIDE 
for: high blood pressure 
Seriousness: HIGH 














































for: heart irregularities 
Seriousness: HIGH  MED 
Discomfort: YES NO 
LESCOL 
for: heart problems 
Seriousness: HIGH  MED 
Discomfort: YES NO 
LEVOTHYROXINE 
for: thyroid 
Seriousness: HIGH  MED 
Discomfort: YES NO 
LIPEDIL 
for: cholesterol 













Diseomfort: YES  
LOMOTIL 
for: irritated bowel 
Seriousness: HIGH 








Discomfort; YES  
LOZIDE 
for: high blood pressure 
Seriousness: HIGH 
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MANDELAMINE 
for: recurrent bladder infection 
Seriousness: HIGH 
Discomfort: YES  
METRONIDAZOLE 
for: pseudo membrane colitis 
Seriousness: HIGH 




Discomfort: YES  
MEVACOR 
for: high cholesterol 
Seriousness: HIGH 
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NITRQLINGUAL SPRAY 
for: heart problems 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NITROGLYCERINE 
for: heart pain 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NITROL CREAM 
for: arthritis 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NITRO PUR (PATCHI 
for: small veins 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NITRQ-DUR 0.2 
for: angina 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NITRQLINGUAL SPRAY 
for: angina 













Discomfort: YES  
NORVASC 
for: high blood pressure 
Seriousness: HIGH 
Discomfort: YES  
NORVASC 
for: still’s disease 
Seriousness: HIGH 
Discomfort: YES  
NORVASC 
for: blood circulation 
Seriousness: HIGH 
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NOVASEN 
for: blood thinner 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NOVASEN 
for: muscle stiffness 
Seriousness: HIGH  MED 
Discomfort: YES NO 
NOVO CYCLOPRINE 
for: muscle relaxer 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NOVO DIAPAM 
for: sedative 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NOVODILTAZEM 
for: unknown 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NOVOSEN ASA ENTERIC 
for: prevent blood clots 
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NOVOHYDRAZIDE 
for: water retention 
Seriousness: HIGH 




Discomfort: YES  
NOVOMEDOPA 
for: high blood pressure 
Seriousness: HIGH 




Discomfort: YES  
NOVOMETROPROL 
for: high blood pressure 
Seriousness: HIGH 
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NOVOPURQL TALLOPURINOL^ 
for: gout 
Seriousness: HIGH  MED 
Discomfort: YES NO 
NOVO-SALMOL 
for: shortness of breath 
Seriousness: HIGH 
Discomfort: YES  
NOVO SALMOL 
for: lung disease 
Seriousness: HIGH 




Discomfort: YES  
NOVOSPIROTON 
for: blood pressure 
Seriousness: HIGH 






















A Metacognitive Model 146 
NOVOSUCRALATE 
for: stomach upset 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NOVOTRIAMIZIDE 
for: high blood pressure 
Seriousness: HIGH  MED 
Discomfort: YES NO 
NOVOTRIMEL 
for: recurrant bladder infection 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NOVOTETRA 
for: rosacea acne 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NQVORANTIDINE 
for: heartbum/acid stomach 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NOVO RANCADINE 
for: acid stomach 
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NOVO RANTIDINE 
for: prevent ulcers 
Seriousness: HIGH  MED 
Diseomfort: YES  NO  
NOVOVEMIDE 
for: fluid 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
NOVOXAPASM 
for: insomnia/being upset 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
OCUVITE 
for: deterioration of eyes 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
OMEPRAZOLE 
for: hernia 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
ONE TOUCH STRIPS 
for: diabetes 
































for: anxiety & depression 
Seriousness: HIGH 
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PRAVACQL 
for: cholesterol 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
PREDNISONE 
for: chronic auto-immune hepatitis 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
PREMARIN 
for: hormone therapy 
Seriousness: HIGH  MED 
Discomfort: YES NO 
PREPULSID 
for: hernia 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
PROPRANOLOL ONDERIDE) 
for: high blood pressure 
Seriousness: HIGH  MED 
Discomfort: YES  NO  
PROPRANOLOL ONDERIDE) 
for: hypertension 
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PROVERA 
for: hormone replacement 
Seriousness: HIGH 










for: stomach problems 
Seriousness: HIGH 




Discomfort: YES  
RHINQCORT SPRAY 










































for: low thyroid, overactive thyroid or fatigue 
Seriousness: HIGH  MED 
Diseomfort: YES NO 
SYNTHROID 
for: stomach trouble or heartburn 
Seriousness: HIGH  MED 
Diseomfort: YES NO 
TAMOXIFEN 
for: cancer prevention 













Discomfort: YES  
TETRACYKLIN 
for: skin eruptions 
Seriousness: HIGH 




Discomfort: YES  
THYROXIN 
for: low thyroid 
Seriousness: HIGH 




Discomfort: YES  
TIMOLOL MILEATE 
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TOSEC 
for: hiatus hernia 
Seriousness: HIGH 






for: stomach upset 
Seriousness: HIGH 
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VASOTEC 
for: high blood pressure 
Seriousness: HIGH 




Discomfort: YES  
VERAPAMIL 
for: irregular heartbeat 
Seriousness: HIGH 








Discomfort: YES  
WARFARES! 
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WARFARIN-SODA 
for: blood circulation 
Seriousness: HIGH 




Discomfort: YES  
WATER PILLS 
for: high blood pressure 
Seriousness: HIGH 




Discomfort: YES  
642 
for: arthritis pain 
Seriousness: HIGH 
Discomfort: YES  
CHLOTRIMAZSLE 
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NASAL SPRAY 
for: dry nasal passages 
Seriousness: HIGH  MED 
Discomfort: YES NO 
LOW 
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APPENDIX C 
INTRODUCTION OF TIME-BASED TASK: 
As the researcher introduces the Personal Information Questionnaire, a request is made to 
the participant: 
“I was wondering if you could do me a favour? While you are filling out these 
questionnaires, Em going to be busy in the other room sorting some papers, could you call me in 
20 minutes because Tm waiting to hear about a scholarship. The person I talked to earlier told 
me to call back around (20 minutes from the start time of the first questionnaire). Em 
afraid I’ll forget to call once I get busy, would you mind calling me? Ell just be outside. 
Thanks.” 
INTRODUCTION OF EVENT-BASED TASK: 
As an afterthought, before the researcher leaves the room the following will be said: 
“Oh, by the way, some of the photocopies are not very clear. Eve gone through most of 
the packages and they look fine, but every once in a while a messy page turns up. If you come 
across any that are unusable, can you please tear it out of the questionnaire and write the name of 
the questionnaire that it came from on the back of it so that I can locate them quickly and pull 
them out myself?” 
At this point the participant will again be reminded to call the researcher in 20 minutes. 
APPENDIX D: The messy page 
When you try to remember 
people you have met/ do 







1 am wood at remembering 
the order that events 
occurred. 




e. disagree strongly 
• 1 am good at remembering 
conversations I have had. 




^ disagree strongly 
37. My memory fcr phone 






^ ffr^Tixpree «-■ 
rementbeg?* 
40. My memory for names has a. agree strongly 
declined greatly in the b. agree 
last 10 years. c. undecided 
d. disagree 
e. disagree strongly 




PROSPECTIVE MEMORY TASKS 
TIME BASED: 
TOTAL TIME IN MINUTES & SECONDS:  
TASK COMPLETION: YES  NO  
COMMENTS:  
EVENT BASED: 
TASK COMPLETION: YES  NO 
COMMENTS:  
^ ^ ^ ?|> ^ ^ ^ ^ ^ ^ 5j> jjc ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ JJH ^ ^ 5f» 5i> ^ ^ ^ ^ 5j> ^ ^ ^ ^ ^ ^ H* ^ 
PRESCRIPTION MEDICATION TEXT 
TIME (MINUTES & SECONDS) SPENT STUDYING TEXT:  
TIME SPENT ON RECALL OF TEXT:  
WORD PAIR TASK 
GLOBAL PREDICTION FOR WORD-PAIR MEMORY:  
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APPENDIX F 
BRAND NAME: MOSETIDIMIDE 
COMMON USES: This medicine is used to treat a variety of intestinal conditions. It may also 
be used to treat other conditions as determined by your doctor. 
HOW TO USE THIS MEDICINE: Follow the directions for using this medicine provided by 
your doctors. This medicine may be taken on an empty stomach or with food. When you first 
start taking this medicine, it may cause dizziness. To prevent this from affecting your daily 
routine: if you are taking 1 dose daily, take it before you go to sleep. If you are taking more than 
one dose, take the first dose as soon as you wake up and the second dose just before bed-time. IF 
YOU MISS A DOSE OF THIS MEDICINE, take it as soon as possible. If it is time for your 
next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 
doses at once. 
CAUTIONS: BEFORE YOU BEGEM TAKING ANY NEW MEDICINE either prescriptions or 
over-the-counter, check with your doctor, nurse or pharmacist. Before using any non- 
prescription medicines which contain ibuprofen or naproxen, check with your doctor. Drinking 
alcohol will intensify the effect of this medication. Do not drive, operate machinery, or do 
anything else that could be dangerous until you know how you react to this medicine. 
POSSIBLE SIDE EFFECTS: CHECK WITH YOUR DOCTOR AS SOON AS POSSIBLE if 
you experience confusion, restlessness, agitation, unusual tiredness or weakness, loss of appetite, 
nausea, vomiting, diarrhea, changes in heart rate, or changes in vision. If you notice other effects 
not listed above, contact your doctor, nurse, or pharmacist. 
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APPENDIX G 
INSTRUCTIONS FOR MEDICATION TEXT: 
Next, I’m going to show you a text about a certain medication. Please read this 
information just as if you were prescribed this medication. The information is fairly typical and 
includes some instructions for taking the medication. 
Please take as long as you wish to read it, but keep in mind to read it just as if you had 
been prescribed the medication by your doctor. I’ll be timing how long you spend reading the 
text, but this is not a timed test. I’m simply interested in how long it takes you to read it as if the 
medication had been prescribed to you. 
IF (AND ONLY IF) THE SUBJECT ASKS ABOUT WHETHER OR NOT THEY WILL 
BE TESTED ON THE INFORMATION: 
After you have finished, I will be asking you for your opinion of the text. 
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APPENDIX I 
MEMORY TASK INSTRUCTIONS 
164 
In a moment, we will begin a recall task. This will require you to remember a list of 
word-pairs that make up actions. For example, EAT / COOKIE is a word-pair that makes up an 
action. As you can see from the example, the word-pairs involve a VERB / NOUN pairing. In 
total, there will be 35 of these word-pairs in the list. All of these word-pairs will make sense to 
you. 
The following steps will tell you what you are going to do. There are three basic steps to 
this procedure; 
1. I (the tester) am going to say each word-pair out loud. 
2. Then, you should repeat the word-pair out loud. 
3. After you say it, you should quickly and efficiently perform the action. 
Now it is time for a quick demonstration so that you know what to do. I am going to 
demonstrate this procedure for you. I will play both my role (the tester) and your role (study 
participant) so that you can just watch and see how it is done. Don’t act anything out now, just 
watch me carefully. 
STEP 1 
The tester says the word-pair out loud. 
SHUFFLE CARDS 
STEP 2 
Now this is when you would repeat the word-pair. 
SHUFFLE CARDS 
STEP 3 
This is when you would perform the task. 
After you have performed the task, like I just showed you, we will go on to the next 
word-pair. So for example, let me demonstrate another one to you. 
STEP 1 
SPELL FRIEND 
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STEP 2 
165 








Now you would say, 
BEND KNEE 
STEPS 
(perform the action) 
At this point, is the three-step procedure clear to you? Do you have any questions? 
Simply remember: (1) say the word-pair, (2) you repeat the word-pair out loud, and (S) then 
perform the action quickly and efficiently. 
Now besides finding out how people will do on this kind of task, I am also interested in 
how they predict their performance. Out of the list of S5 word-pairs, how many do you think you 
will remember? 
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APPENDIX J 
ID# 
In the spaces below, please write down as many word-pairs as you can remember from the list 
you 
have just heard. You may write down the word-pairs in any order you wish. You will have a 
maximum of seven (7) minutes to complete the task. 
1. /  19. / 
2. /  20. / 
/ 21. / 
4. / 22. / 
6. /  23. / 
7. /  24. / 
8. /  25. / 
9. /  26. / 
10. / 27. / 
11. / 
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APPENDIX K 
Memory for Medications Questionnaire 
167 
Directions 
In this questionnaire, we would like you to tell us about some strategies that you may use 
to help you remember to take your medications correctly. We are interested in how people to 
manage to remember how much medication to take (e.g., how many pills) and what time of day 
to take the medication. There are no right or wrong answers to these questions because people 
are different. Some people use strategies to help them remember, and others do not. Please take 
your time and answer each of these questions to the best of your ability. 
For each of the strategies that are listed, there are two questions: 
The first question asks you how often you use this strategy. This question is followed by five 
choices. Draw a circle around the letter corresponding to your choice. Mark only one letter for 
each statement. 
For example; 






The second question asks you whether you think this strategy is effective in helping people 
remember to take their medications. 
- If you use this strategy, or have ever used this strategy, tell us whether you found it to be 
helpful in helping you remember. 
- If you answered NEVER in the first question, then please give us your opinion of how 
effective you believe this strategy would be if you were to use it. 
For example: 
 I believe that making a list of my prescribed medications is (or would be) helpful: 




e. disagree strongly 
Please keep these points in mind: 
- Answer every question, even if it doesn’t seem to apply to you very well. 
- Answer as honestly as you can what is true for you. Please do not mark something because it 
seems like the “right thing to say”. 
A Metacognitive Model 168 






I believe that using a clock or watch alarm to remind me when it is time to take my 
medication is (or would be) helpful: 




e. disagree strongly 






I believe that asking my doctor to speak slowly when giving me medication instructions is 
(or would be) helpful: 




e. disagree strongly 






I believe that asking other people to remind me what time to take my medication is (or 
would be) helpful: 
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e. disagree strongly 






I believe that counting on other people to remind me what time to take my medication is 
(or would be) helpful: 




e. disagree strongly 
5) Do you use a dated pillbox to help you make sure you take the right amount of 






I believe that using a dated pillbox to help me make sure to take the right amount of 
medication per day is (or would be) helpful: 




e. disagree strongly 
6) When you try to learn the names of your prescriptions, do you try to associate the name of 






I believe that when you try to learn the names of your prescriptions, associating the name 
of a medication with the name of the condition is (or would be) helpful: 
a. agree strongly 




e. disagree strongly 
7) When you want to remember written medication instructions (pill bottle labels, written 






I believe that when I want to remember written medication instructions, reading them 
more than once is (or would be) helpful: 




e. disagree strongly 







I believe that leaving notes for myself in prominent places to remind me when to take my 
medications is (or would be) helpful: 




e. disagree strongly 
9) When you want to remember when to take your medications, do you try to relate the 
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I believe that when 1 want to remember when to take my medications, that relating the 
medication times to something else 1 routinely do (like meal times) is (or would be) 
helpful: 




e. disagree strongly 
10) At the beginning or the day, do you think about when you need to take your medication so 






I believe that thinking about when I need to take my medications at the beginning of the 
day so 1 can include my medications into my day’s schedule is (or would be) helpful: 




e. disagree strongly 
11) Do you ask other people to remind you how to take your medication? (e.g. taking your 






1 believe that asking other people to remind me how to take my medication is (or would 
be) helpful: 




e. disagree strongly 
12) Do you count on other people to remind you how to take your medication (e.g., taking 
your medication with milk, or avoiding certain foods)? 
a. never 





I believe that counting on other people to remind me how to take my medication is (or 
would be) helpful: 




e. disagree strongly 
13) When you are receiving instructions on when and how to take your medications, do you 






I believe that making mental images or pictures when I am receiving instructions on when 
and how to take my medications is (or would be) helpful: 




e. disagree strongly 
14) Do you spend a lot of time making plans or using aids for memory to help you take your 






I believe that spending a lot of time making plans or using aids for memory to help me 
take my medications on time is (or would be) helpful: 




e. disagree strongly 
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15) When you have trouble remembering to take your medications, do you try to relate the 
medication times to some event that is specific to that day (e.g., I need to take my pill 






I believe that trying to relate my medication times to some event that is speeific to that 
day is (or would be) helpful: 




e. disagree strongly 
16) Do you regularly repeat to yourself the instructions for taking a prescription that you’ve 






I believe that regularly repeating to myself the instructions for taking a prescription that 
I’ve been taking for a long time is (or would be) helpful: 




e. disagree strongly 







I believe that leaving my pills in a prominent place to remind me to take my medication is 
(or would be) helpful: 
a. agree strongly 




e. disagree strongly 






I believe that writing myself notes as reminders of my medication instructions is (or 
would be) helpful: 




e. disagree strongly 
19) When you want to remember the name of a particular medication, do you ask somebody 






I believe that when I want to remember the name of a particular medication, asking 
somebody else to help me remember is (or would be) helpful: 




e. disagree strongly 
20) Do you try to concentrate hard when reading medication instructions (e.g., pill bottle 
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I believe that concentrating hard when reading medication instructions is (or would be) 
helpful: 




e. disagree strongly 
21) When you want to remember written medication instructions (e.g., pill bottle labels, 






I believe that when I want to remember written medication instructions, reading them 
more slowly is (or would be) helpful: 




e. disagree strongly 
22) Do you leave notes for yourself in prominent places to remind you how to take your 






I believe that leaving notes for myself in prominent places to remind me how to take my 
medications is (or would be) helpful: 




e. disagree strongly 




A Metacognitive Model 176 
d. often 
e. always 
I believe that making a mark on a calendar when I’ve taken my medication each day is (or 
would be) helpful: 




e. disagree strongly 
24) When you are trying to learn new medication instructions, do you mentally repeat the 






I believe that when I am trying to learn new medication instructions, mentally repeating 
the instructions is (or would be) helpful: 




e. disagree strongly 
25) Do you ask other people to remind you about the amounts of a medication to take (e.g., 






1 believe that asking other people to remind me about the amounts of a medication to take 
is (or would be) helpful: 




e. disagree strongly 
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26) Do you count on other people to remind you about the amounts of medication to take 






I believe that counting on other people to remind me about the amounts of a medication 
to take is (or would be) helpful: 




e. disagree strongly 
27) Do you try to concentrate hard when receiving verbal medication instructions from your 






I believe that concentrating hard when receiving verbal medication instructions from my 
doctor or pharmacist is (or would be) helpful: 




e. disagree strongly 







I believe that keeping a written list of the times and amounts of the medications that I 
need to take is (or would be) helpful: 
a. agree strongly 
b. agree 
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c. undecided 
d. disagree 
e. disagree strongly 






1 believe that trying hard to learn the amounts to take when I am prescribed a new 
medication is (or would be) helpful: 




e. disagree strongly 
30) When you get a new prescription for medication, do you ask somebody else to help you 







I believe that when I get a new prescription for medication, asking somebody else to help 
me remember when to take my medication and how to take it is (or would be) helpful: 




e. disagree strongly 
31) When you get a new prescription for medication, do you count on somebody else to help 
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I believe that when I get a new prescription for medication, counting on somebody else to 
help me remember when to take my medication and how to take it is (or would be) 
helpful: 




e. disagree strongly 







I believe that when I get a new prescription, concentrating a lot to learn the times for 
taking my medication is (or would be) helpful: 




e. disagree strongly 
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33) Please list any other strategies that you have ever used to help you remember your 
medication instructions. 
STRATEGY 1: 






I believe this strategy is (or would be) helpful: 




e. disagree strongly 
STRATEGY 2: 






I believe this strategy is (or would be) helpful: 




e. disagree strongly 
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STRATEGY 3: 






I believe this strategy is (or would be) helpful: 




e. disagree strongly 





Different people use their memory in different ways in their everyday lives. For example, some 
people make shopping lists, whereas others do not. Some people are good at remembering 
names, whereas others are not. 
In this questionnaire, we would like you to tell us how you use your memory and how you feel 
about it. There are no right or wrong answers to these questions because people are different. 
Please take your times and answer each of these questions to the best of your ability. 
Each question is followed by five choices. Draw a circle around the letter corresponding to your 
choice. Mark only one letter for each statement. 
Some of the questions ask your opinion about memory-related statements; for example: 
My memory will get worse as 
I get older 




e. disagree strongly 
In this example you could, of course, choose any one of the answers. It you agree strongly with 
the statement you would circle a. If you disagree strongly you would circle letter e. The b and d 
answers indicate less strong agreement or disagreement. The letter c answer gives you a middle 
choice, but don’t use the c unless you really can’t decide on any of the other responses. 
Some of the questions ask how often you do certain things that may be related to your memory. 
For example: 
Do you make a list of things 







Again, you could choose any one of the answers. Choose the one that comes closest to what you 
usually do. Don’t worry if the time estimate is not exact, or if there are some exceptions. 
Keep these points in mind: 
a) Answer every question, even if it doesn’t seem to apply to you very well. 
b) Answer as honestly as you can what is true for you. Please do not mark 
something because it seems like the “right thing to say”. 
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e. disagree strongly 
Do you keep a list or 
otherwise note important 







I get upset when I cannot 
remember something. 




e. disagree strongly 
When you are looking for 
something you have 
recently misplaced, do 
you try to retrace your 






I find it harder to 
remember things when I am 
upset. 




e. disagree strongly 
I am good at remembering 
birthdates. 




e. disagree strongly 
I can remember things as 
well as always. 




e. disagree strongly 
When you have not 
finished reading a book 
or magazine, do you 
somehow note the place 
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9. I get anxious when I am 
asked to remember 
something. 




e. disagree strongly 
10. I’m less efficient at 
remembering things now 
then I used to be. 




e. disagree strongly 
11 I have difficulty 
remembering things when I 
am anxious. 




e. disagree strongly 
12. The older I get the 
harder it is to remember 
clearly. 




e. disagree strongly 
13. Do you think about the 
day’s activities at the 
beginning of the day so 
you can remember what you 






14. lam just as good at 
remember as I ever was. 




e. disagree strongly 
15. I have no trouble keeping 
track of my appointments. 




e. disagree strongly 
16. Most people find it easier to 
remember directions to places 
they want or need to go than 
to places they know they 
will never be going. 




e. disagree strongly 
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17. I am usually uneasy when 
I attempt a problem that 
requires me to use my memory. 




e. disagree strongly 
18. I feel j ittery if I have 
to introduce someone I 
just met. 




e. disagree strongly 
19. Do you post reminders of 
things you need to do in 
a prominent place, such 







20. I am poor at remembering 
trivia. 




e. disagree strongly 
21. I am much worse now at 
remembering the content 
of news articles and 
broadcasts than I was 10 
years ago. 




e. disagree strongly 
22. Do you routinely keep 
things in a familiar spot 
so you won’t forget them 







23. Compared to 10 years ago, 
I am much worse at 
remembering titles of 
books, films, or plays. 




e. disagree strongly 
24. I remember my dreams much 
less now than 10 years 
ago. 




e. disagree strongly 
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25. I can’t expect to be good 
at remembering postal 
codes at my age. 




e. disagree strongly 
26. I have little control 
over my memory ability. 




e. disagree strongly 
27. When you want to take something 
with you, do you leave it in an 
obvious, prominent place, such as 







28. I misplace things more 
frequently now than when 
1 was younger. 




e. disagree strongly 
29. As people get older they 
tend to forget where they 
put things more frequently. 




e. disagree strongly 
30. Compared to ten years 
ago, I now forget many 
more appointments. 




e. disagree strongly 
31. If I am put on the spot 
to remember names, I know 
I will have difficulty 
doing it. 




e. disagree strongly 
32. My memory for important 
events has improved over 
the last 10 years. 




e. disagree strongly 
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33. When you try to remember 
people you have met, do 







34. lam good at remembering 
the order that events 
occurred. 




e. disagree strongly 
35. lam good at remembering 
conversations I have had. 




e. disagree strongly 
I would feel on edge 
right now if I had to 
take a memory test or 
something similar. 




e. disagree strongly 
My memory for phone 
numbers will decline as I 
get older. 




e. disagree strongly 
38. My memory for dates has 
deelined greatly in the 
last 10 years. 




e. disagree strongly 
39. When you have trouble remembering 
something, do you try to remember 







40. My memory for names has 
declined greatly in the 
last 10 years. 




e. disagree strongly 
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41, I often forget who was 
with me at events I have 
attended. 




e. disagree strongly 
42. Do you consciously 
attempt to reconstruct 
the day’s events in order 






43. As long as I exercise my 
memory it will not 
decline. 




e. disagree strongly 
44. lam good at remembering 
the places I have been. 




e. disagree strongly 
45. I know if I keep using my 
memory I will never lose it. 




e. disagree strongly 
46. Do you try to relate something 
you want to remember to 
something else hoping that this 
will increase the likelihood of 






47. When I am tense and 
uneasy at a social 
gathering I cannot 
remember names very well. 




e. disagree strongly 
48. Do you try to concentrate 
hard on something you 
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49. It’s up to me to keep my 
remembering abilities 
from deteriorating. 




e. disagree strongly 
50. When someone I don’t know 
very well asks me to 
remember something I get 
nervous. 




e. disagree strongly 
51. I have no trouble 
remembering where I have 
put things. 




e. disagree strongly 
52. Even If I work on it, my 
memory ability will go 
downhill. 
Do you make mental images 
or pictures to help you 
remember? 




e. disagree strongly 





54. I know of someone in my 
family whose memory 
improved significantly in 
old age. 




e. disagree strongly 
55. I am good at remembering 
things like recipes. 




e. disagree strongly 
56. I get anxious when I have 
to do something I haven’t 
done for a long time. 




e. disagree strongly 
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57. Do you mentally repeat 







58. My memory has improved 
greatly in the last 10 
years. 




e. disagree strongly 
59. I get tense and anxious 
when I feel my memory is 
not as good as other 
peoples’. 
Do you ask other people 
to remind you of 
something? 




e. disagree strongly 





61. I do not get flustered 
when I am put on the spot 
to remember new things. 




e. disagree strongly 
62. I am good at remembering 
titles of books, films 
and plays. 




e. disagree strongly 
63. My memory has declined 
greatly in the last 10 
years. 




e. disagree strongly 
64. I have no trouble 
remembering lyrics of 
songs. 




e. disagree strongly 
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65. My memory will get better 
as I get older. 




e. disagree strongly 







67. I am good at remembering 
names of musical 
selections. 




e. disagree strongly 
68. After I read a book I 
have no difficulty 
remembering factual 
information from it. 




e. disagree strongly 
69. Do you write appointments 







70. I would feel very anxious 
if I visited a new place 
and had to remember how 
to find my way back. 




e. disagree strongly 
71. lam good at remembering 
the content of news 
articles and broadcasts. 




e. disagree strongly 
72. No matter how hard a 
person works on his 
memory, it cannot be 
improved very much. 




e. disagree strongly 
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73. If I were to work on my 
memory I could improve 
it. 
74. Remembering the plots of 
stories and novels is 
easy for me. 
75. lam usually able to 
remember exactly where I 
read or heard a specific 
thing. 
76. I think a good memory 
comes mostly from working 
at it. 
77. Do you write shopping 
lists? 




e. disagree strongly 




e. disagree strongly 




e. disagree strongly 










A Metacognitive Model 193 
APPENDIX M 
YES, I AM INTERESTED IN PARTICIPATING IN THE SALT PROJECT. 
(Your name and phone number will be used 
only to schedule your appointment) 
NAME:  
YEAR OF BIRTH:  SEX:  
PHONE NUMBER: 
HOME:  WORK:  
ADDRESS: 
THE BEST TIMES TO REACH ME ARE: 
Would it be alright if we contacted you in the future when we are conducting a 
different type of study? 
YES NO 
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APPENDIX N 
MEMORY FOR MEDICATIONS 
Purpose of the Study 
The purpose of this study is to investigate various important measures that 
may affect medication taking. 
Procedures to be Followed 
During this study you will be asked to complete a number of 
questionnaires and perform a few memory tasks. More specifically we will ask 
you to: 
1) Tell us about your age, educational background, health status, and 
give descriptions of any current medications that you are taking. 
2) Tell us how you feel about your memory. 
3) Described the different strategies that you use to help you 
remember to take your medications as well as your personal 
opinions about the usefulness of these strategies. 
4) Perform a few memory tasks. 
Time Required 
Your participation will last about 1.5 to 2 hours. 
Risks and Benefits 
Being asked to perform a task or take a test can sometimes be a stressful 
experience. It is, however, through the cooperation of individuals such as yourself 
that we with interests in Life-Span Development Psychology are able to 
understand how adults remember. 
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LAKEHEAD UNIVERSITY 
INFORMED CONSENT FORM 
195 
Title of Investigation: TAKING MEDICATIONS 
Investigators: Leslie McDonald-Miszczak, Ph.D 
Florence MacLean, Psyc. Honors Program 
This is to certify that I, hereby agree to 
participate as a volunteer in a scientific study as an authorized part of the 
educational research program at Lakehead University. 
The study and my part in it have been defined by the investigator and I 
understand the summary. The procedures of this study are described on the first 
page of this form and have been presented in detail. 
I have been given an opportunity to ask whatever questions I may have had 
and all such questions and inquiries have been answered to my satisfaction. 
I understand that I am free to refuse to participate in any specific task or to 
refuse to answer any specific test questions. 
I understand that any data or answers to questions will remain confidential 
with regard to my identity. 
I certify that to the best of my knowledge and beliefs, I have no physical 
illness or other problem that would increase the risk to me due to participation in 
this study. 
I FURTHER UNDERSTAND THAT I AM FREE TO WITHDRAW MY 
CONSENT AND TERMINATE MY PARTICIPATION AT ANY TIME. 
Date: Signature of Participant 
I, the undersigned, have defined and fully explained the above to the participant in 
detail, and to my best knowledge and belief it was understood. 
Date:  Signature of Investigator  
A Metacognitive Model 
APPENDIX P 
PERSONAL INFORMATION SHEET 
196 
In order to better understand the results of our study, we need to know a few 
things about you and your background. This information will be used for research 
purposes and it will be kept strictly confidential. 
1) My birth date is:  
(day) (month) (year) 
2) My gender is; 
a. ale b. female 





e. common-law relationship 
4) How old do you feel mentally? years 
5) How old do you feel physically? years 
6) Who else lives in your home? (circle all that apply) 
a. my spouse 
b. my adult son or daughter 
c. one or more children 
d. an adult who is not related to me 
e. I live alone 
f. other (please specify)  
7) How often do you engage in social activities such as visiting friends at 
their house, eating at restaurants, attending musical performances, and 
other similar activities? 
a. less than once a month 
b. 1-2 times a month 
c. 1 - 2 times a week 
d. more than 3 times a week 
8) How often do you have wine, beer or other alcoholic drinks? 
a. about once a day f. about once a year or less 
b. 1-2 times a week g. never 
c. 2-3 times a week 
d. about once a month 
e. several times a year 
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9) When you have alcoholic beverages, how much do you have? 
a. I never drink alcoholic beverages 
b. 1 - 2 drinks 
c. 3 - 4 drinks 
d. 5 - 6 drinks 
e. more than six drinks 
10) Please indicate the level of education that you have completed: 
a. Did you complete primary school (Grade 8)7 
a. yes 
b. no 
b. Did you complete high school (Grade 12)7 
a. yes 
b. no 
c. How many years did you attend college, university, or training school? 
 years 
11) Currently, I am (please circle all that apply) 
a. employed full time 
b. employed part time 
c. retired 
d. full-time homemaker 
e. part-time homemaker 
f doing volunteer work 
g. a full-time student 
h. a part-time student 
i. other  
12) If you are retired: 
When did you retire from full-time employment?  
13) What is your primary occupation? (If you are retired, please indicate your 
former occupation)  
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THE FOLLOWING ARE A FEW QUESTIONS ABOUT YOUR GENERAL 
HEALTH: 
14) Compared to a perfect state of health, I believe my overall health to be 
(please circle one): 




e. very poor 
15) Compare to other people my age, I believe my overall health to be (please 
circle one): 




e. very poor 
16) 1 use the following corrective lenses for my eyesight: 
a. I don’t use glasses or contact lenses 
b. glasses or contact lenses for distances 
c. glasses or contact lenses for reading or close work 
17) Do you require a hearing aid? 
a. yes 
b. no 
18) How many times have you visited your doctor in the past 12 months? 
a. none 
b. once 
c. 2 - 5 times 
d. 6 - 12 times 
e. over 12 times 
19) How many nights have you spent in a hospital or nursing home during the 
last 12 months? 
a. none 
b. 1 - 6 nights 
c. 1 - 3 weeks 
d. 1 month or more 
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20) Please indicate which medical conditions you have experienced in the last 













m. heart disease 
n. hepatitis 
o. high blood pressure 
p. influenza 
q. kidney disease 
r. multiple sclerosis 
s. Parkinson’s disease 
t. pneumonia 
u. polio effects 
V. thyroid disease 
w. tuberculosis 
X. stroke or effects of stroke 
y. ulcers 
z. other, please specify:  
21) Have you had the following surgeries during the last 5 years? (circle all 
that apply) 
a. appendectomy 
b. back surgery 
c. endarterectomy/carotid surgery (to clear arteries in the neck) 
d. gallbladder surgery 
e. hernia repair 
f. hysterectomy 
g. mastectomy 
h. open heart surgery 
i. prostrate surgery 
j. tonsillectomy 
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22) How many different medications has your doctor prescribed to you in the 
last two years? 
a. none 
b. 1-2 different medications 
c. 3-4 different medications 
d. 5 - 6 different medications 
e. 7 or more different medications 
23) How many different prescribed medications are you taking now? 
a. none 
b. 1-2 different medications 
c. 3 - 4 different medications 
d. 5 - 6 different medications 
e. 7 or more different medications 
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APPENDIX Q 
MOOD QUESTIONNAIRE 
In this booklet, there are statements about the way that most people feel at 
one time or another. There is no such thing as a “right” or “wrong” answers, 
because people are different. All you have to do is answer the statements 
according to how you have felt during the past week. Don’t answer according to 
how you usually feel, but rather how you have felt during the past week. Each 
statement is followed by four choices. Mark a circle around the letter 
corresponding to your choice. Mark only one letter for each statement. For 
example: 
During the past week, I was happy. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
In the example, you could, of course, choose any one of the answers. If you felt 
really happy, you would choose and circle d. If you felt very unhappy you would 
circle a. The b. and c. answers give you middle choices. 
Keep these points in mind: 
a) Don’t spend too much time thinking about your answer. Give the first 
natural answer as it comes to you. 
b) Answer every question, even if it doesn’t seem to apply to you very well. 
c) Answer as honestly as you can what is true of you. Please do not mark 
something because it seems like “the right thing to say”. 
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1. During the past week I was bothered by things that usually don’t bother 
me. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
2. During the past week I did not feel like eating; my appetite was poor. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
3. During the past week I felt that I could not shake off the blues even with 
help from my family or friends. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
4. During the past week I felt that 1 was just as good as other people. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
5. During the past week I had trouble keeping my mind on what I was doing. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
6. During the past week I felt depressed. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
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7. During the past week I felt that everything 1 did was an effort. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
8. During the past week I felt hopeful about the future. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
9. During the past week I thought my life had been a failure. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
10. During the past week I felt fearful. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
11. During the past week my sleep was restless. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
12. During the past week I was happy. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
13. During the past week I talked less than usual. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
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14. During the past week I felt lonely. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
15. During the past week people were unfriendly. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
16. During the past week I enjoyed life. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
17. During the past week I had crying spells. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
18. During the past week 1 felt sad. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
19. During the past week I felt that people dislike me. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 
20. During the past week I could not get “going”. 
a. Rarely or none of the time (less than one a day) 
b. Some or a little of the time (1-2 days) 
c. Occasionally or a moderate amount of the time (3-4 days) 
d. Most or all of the time (5-7 days) 




Now that we are finished the session, I would like to tell you some things about 
the study that you have just participated in. 
First of all, I would like to thank you for participating in this study. Without 
individuals such as yourself, researchers interested in developmental psychology 
would not be able to examine many important issues. 
The purpose of this research was to see whether there are age differences in how 
people remember to take their medications. Obviously, remembering to take our 
medications is extremely important for maintaining good health and promoting 
optimal development in life. Flowever, many older adults are prescribed several 
medications that may have very complicated dosage schedules. We are interested 
in how older adults remember to take their medications (as compared with 
younger adults) and we are interested in other factors that might be related to their 
self-reported compliance. 
Other researchers have found that adults’ (both younger and older) reports of 
compliance with their medications is not very accurate. Generally, when our 
doctor asks us how accurately we are sticking to our medication regimen, we are 
not very accurate when we reply. Although this can be a very complicated 
question to answer, the accuracy of such feedback information is extremely 
important to us and the physician. 
To understand the relation between our self-reported compliance rates and our 
memory ability, we asked you to perform a variety of memory tests in this study. 
In order to get an accurate measure of some types of memory, we asked you to (a) 
tear out the messy page from your questionnaire booklet and write the name of the 
questionnaire on the back, and (b) call the researcher in 20 minutes so that she 
could make an important phone call. The tasks were actually a planned portion of 
the experiment so that we could measure your memory for performing these tasks 
(just as if we had asked you to remember to take a medication when you saw it, or 
remember to take your next pill in 20 minutes). We apologize for giving you a 
cover story for these tasks, but this information is crucial for understanding how 
different parts of the memory system are used to remember our medications. 
We also asked you to remember some everyday actions and to recall a text 
describing some medication instructions. We will examine the relation between 
adults’ performance on all these different memory tasks and their self-reported 
medication taking behaviours. 
In an initial study, we found that older adults’ beliefs about their memory (in 
general) were a primary motivator for (a) using strategies to remember to take 
medications and (b) self-reported medication compliance rates. Perhaps, when the 
doctor asks us how our medication-taking is going, we base our reply on our 
general beliefs about our memory rather than on our specific memory for our 
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medications. The role of memory beliefs may be very important. Often, when 
health professionals address the topic of improving medication compliance in 
older adults, they point to educating adults about important information (i.e., the 
seriousness of the illness, the side-effects, dosage information). Although we 
agree that such education is crucial, our results suggest that older adults’ beliefs 
about their memory ability should be addressed in such educational programs. 
Again, we thank you for taking part in our study. We hope that the results of this 
work will be helpful for (a) furthering scientific understanding of memory 
changes across adulthood, and (b) creating comprehensive medication adherence 
programs to help some older adults remember to take their medications more 
accurately. 
Please do not hesitate to ask us any questions about this study. We encourage and 
look forward to your input. 
Thanks again! 
